{
  "title": "Estenosis carotídea",
  "guid": "B05E129562114556443CCFED",
  "filepath": "/sessions/bold-jolly-cerf/mnt/Dropbox/- Esquemas/- Entidades clínicas/General/Estenosis carotídea-2025.smmx",
  "root": {
    "id": "0",
    "parent": "-1",
    "text": "Estenosis\ncarotídea",
    "guid": "slaQH0JDhzxExyweJa6qNQ",
    "children": [
      {
        "id": "1",
        "parent": "0",
        "text": "Definición",
        "guid": "vJ6MIB_7TYJ2dfXP9fCNaw",
        "children": [
          {
            "id": "2",
            "parent": "1",
            "text": "Estenosis carotídea",
            "guid": "",
            "children": [
              {
                "id": "3",
                "parent": "2",
                "text": "• Estrechamiento de la a. carótida (gralte x aterosclerosis)",
                "guid": "KPGuD4fz8TSpXe3cNX3SHQ",
                "children": []
              },
              {
                "id": "4",
                "parent": "2",
                "text": "• → ↑riesgo de AIT y AVC",
                "guid": "tkgI_qtdKyuUgibeN7S6fg",
                "children": []
              },
              {
                "id": "5",
                "parent": "2",
                "text": "Sinónimos",
                "guid": "H20DWFo0yL2Spj5v-xLVAg",
                "children": [
                  {
                    "id": "6",
                    "parent": "5",
                    "text": "• Enfermedad de la a. carótida",
                    "guid": "9YbJREl9DEJ5x3ZLv57UxA",
                    "children": []
                  },
                  {
                    "id": "7",
                    "parent": "5",
                    "text": "• Aterosclerosis de la a. carótida",
                    "guid": "dX9PxV5h-UcSjGCGTAUk8A",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "8",
            "parent": "1",
            "text": "Extracraneal",
            "guid": "lJTxvxYSmWiODzNiRUxAaw",
            "children": [
              {
                "id": "9",
                "parent": "8",
                "text": "• Enfermedad de a. carótidas y vertebrales → +freq x aterosclerosis",
                "guid": "qK4ecRAa1rMSswJJU3I5bQ",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "10",
        "parent": "0",
        "text": "Epidemiología",
        "guid": "4Y1qoA6yw8VASx03AdT2eg",
        "children": [
          {
            "id": "11",
            "parent": "10",
            "text": "Quiénes\n+afectados",
            "guid": "f3yFmbto6W1MFsJUksmlLA",
            "children": [
              {
                "id": "12",
                "parent": "11",
                "text": "• Varones ~2:1 (estenosis carótida asintomática)",
                "guid": "GwaelUoWhRfDCC5aQzn39A",
                "children": []
              },
              {
                "id": "13",
                "parent": "11",
                "text": "• >60 años",
                "guid": "ratdIPupq18xegCaNBc-bQ",
                "children": []
              },
              {
                "id": "14",
                "parent": "11",
                "text": "• Enf. Arterial periférica, Enf. Coronaria, Aneurisma aórtico",
                "guid": "wEn_r1C1f14bbkB-CX6a9Q",
                "children": []
              },
              {
                "id": "15",
                "parent": "11",
                "text": "• DM, HTA, Dislipidemia",
                "guid": "XgBrsL1PIgHGTbKjFwRQ7Q",
                "children": []
              },
              {
                "id": "16",
                "parent": "11",
                "text": "• Tabaquismo",
                "guid": "7UkjeWzVUm5LkNkXBi6CZQ",
                "children": []
              }
            ]
          },
          {
            "id": "17",
            "parent": "10",
            "text": "Incidencia/Prevalencia",
            "guid": "nWZJLCwQDA10RyRdvUxQrA",
            "children": [
              {
                "id": "18",
                "parent": "17",
                "text": "• EE.UU:",
                "guid": "3wAFTq5Abf6e0aO90VySuQ",
                "children": [
                  {
                    "id": "19",
                    "parent": "18",
                    "text": "- Asintomática ≥50% estenosis: 2%-9% poblac. gral",
                    "guid": "Srk3Cmv7ERrgoLeZ1h6zSw",
                    "children": []
                  },
                  {
                    "id": "20",
                    "parent": "18",
                    "text": "- 5%-9% en >65 años",
                    "guid": "AshGjvc6pFsaKkho77t7jQ",
                    "children": []
                  },
                  {
                    "id": "21",
                    "parent": "18",
                    "text": "- 11%-26% en Enf. Coronaria",
                    "guid": "XtDYYnhHjCbzqjVcjuMPmA",
                    "children": []
                  },
                  {
                    "id": "22",
                    "parent": "18",
                    "text": "- 25%-49% en Enf. Arterial periférica",
                    "guid": "-Z5Rh3NH1C55IzsXdhcnng",
                    "children": []
                  },
                  {
                    "id": "23",
                    "parent": "18",
                    "text": "- 58% placa carotídea (N. Manhattan Study)",
                    "guid": "VanGhwFp-J3rquL3bhv0Ag",
                    "children": []
                  },
                  {
                    "id": "24",
                    "parent": "18",
                    "text": "- 36% >50% estenosis carotídea en px pre-CABG",
                    "guid": "SvZLmjns142fGqEhcowNYQ",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "25",
        "parent": "0",
        "text": "Patogenia\n(Aterosclerosis)",
        "guid": "bLJ8sZ3Btz1nl-Jv3eDwGg",
        "children": [
          {
            "id": "26",
            "parent": "25",
            "text": "Etiología",
            "guid": "9nnXb67ggoEmLeoiJ3iU3Q",
            "children": [
              {
                "id": "27",
                "parent": "26",
                "text": "• Causa principal: Aterosclerosis (bifurcación carótida)",
                "guid": "_Uhip7UkCT8Vi_yR8NC7ew",
                "children": []
              },
              {
                "id": "28",
                "parent": "26",
                "text": "• Otras: Disección, Fibromuscular dysplasia, Takayasu, Arteritis células gigantes,\nRadioterapia, Variantes anatómicas, Cuerpo carotídeo, Trombo flotante",
                "guid": "aQkzRapGLabUtaQdAo79QQ",
                "children": []
              }
            ]
          },
          {
            "id": "29",
            "parent": "25",
            "text": "• Acumulación LDL subíntima → oxidación → citoquinas → reclutamiento monocitos → macrófagos espumosos",
            "guid": "BeB3qElDu4hnRhU3Apdeow",
            "children": []
          },
          {
            "id": "30",
            "parent": "25",
            "text": "• Cél. musc. lisas migran y proliferan en íntima",
            "guid": "_5mh84bfKFkaEndF7rBiZw",
            "children": []
          },
          {
            "id": "31",
            "parent": "25",
            "text": "• Núcleo lipídico (colesterol libre) crece → cap fibroso puede romperse → trombosis in situ o embolia distal",
            "guid": "kqfu3XMvlnES4oT0BJg17w",
            "children": []
          },
          {
            "id": "32",
            "parent": "25",
            "text": "• Riesgo ↑AVC con: estenosis +grave, placa ulcerada/irregular, hemorrágica, lipídica, cap fibroso delgado o roto",
            "guid": "vJNZN9znSwFIFLIM_nrVeQ",
            "children": []
          }
        ]
      },
      {
        "id": "33",
        "parent": "0",
        "text": "Factores\nde Riesgo",
        "guid": "J9VuNgG33CLtqwlm04YTDw",
        "children": [
          {
            "id": "34",
            "parent": "33",
            "text": "Desarrollo de\naterosclerosis",
            "guid": "b_6atev9CxDW7YADZdfGPQ",
            "children": [
              {
                "id": "35",
                "parent": "34",
                "text": "• Edad avanzada",
                "guid": "6m08VK8n4wwnupc6Vfn7nw",
                "children": []
              },
              {
                "id": "36",
                "parent": "34",
                "text": "• Sexo masculino",
                "guid": "9dC-hsCA_AtksvJ4SQBQRg",
                "children": []
              },
              {
                "id": "37",
                "parent": "34",
                "text": "• DM",
                "guid": "fwxnNOVtQPBp6qOf5XfIZw",
                "children": []
              },
              {
                "id": "38",
                "parent": "34",
                "text": "• HTA",
                "guid": "-5B4jLyNTO7lmjDlPT9afg",
                "children": []
              },
              {
                "id": "39",
                "parent": "34",
                "text": "• Tabaquismo",
                "guid": "f3HavCdfp0JeT2RBksQaDg",
                "children": []
              },
              {
                "id": "40",
                "parent": "34",
                "text": "• Dislipidemia",
                "guid": "zqNtEazTpT7neo7CtI-37A",
                "children": []
              }
            ]
          },
          {
            "id": "41",
            "parent": "33",
            "text": "Progresión de\naterosclerosis",
            "guid": "iMAEPY9UO7wvB5po_1cJiw",
            "children": [
              {
                "id": "42",
                "parent": "41",
                "text": "• Mayor duración de la estenosis",
                "guid": "zpY-cvc0YYTdptMX-07abA",
                "children": []
              },
              {
                "id": "43",
                "parent": "41",
                "text": "• Mayor % de estenosis (estenosis moderada x5 +prob de progresión vs leve)",
                "guid": "1M_hwWnfVh8PuJ3hgK2OwQ",
                "children": []
              },
              {
                "id": "44",
                "parent": "41",
                "text": "• DM",
                "guid": "SULaEvQLMs7JLi_VjU0pAA",
                "children": []
              },
              {
                "id": "45",
                "parent": "41",
                "text": "• Tabaquismo",
                "guid": "qoyQ3NEk9YgpmtpT4oEBww",
                "children": []
              },
              {
                "id": "46",
                "parent": "41",
                "text": "• HTA",
                "guid": "V_KhOilb-AKAglrxuI8n2w",
                "children": []
              },
              {
                "id": "47",
                "parent": "41",
                "text": "• Placa heterogénea",
                "guid": "3-4sG8psYS2eK7fYOLTtXQ",
                "children": []
              },
              {
                "id": "48",
                "parent": "41",
                "text": "• Afección contralateral",
                "guid": "_VkdfcgP3pYz2mqz4G0LBQ",
                "children": []
              },
              {
                "id": "49",
                "parent": "41",
                "text": "• Enf. Coronaria",
                "guid": "dBuEfuL7lRdnocDtYBNwVA",
                "children": []
              }
            ]
          },
          {
            "id": "50",
            "parent": "33",
            "text": "Condiciones\nAsociadas",
            "guid": "soO4oSk29QB2bMRyLmtaqQ",
            "children": [
              {
                "id": "51",
                "parent": "50",
                "text": "• Enf. Arterial periférica",
                "guid": "1AGzB2SQ8Pn_nik0f4whyA",
                "children": []
              },
              {
                "id": "52",
                "parent": "50",
                "text": "• Enf. Coronaria",
                "guid": "CbZAGV8ZHadtdX2KWzX4HA",
                "children": []
              },
              {
                "id": "53",
                "parent": "50",
                "text": "• Enf. Aneurismática aórtica",
                "guid": "pGaI8wQCUT3HvWV3CdWSqA",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "54",
        "parent": "0",
        "text": "Evaluación",
        "guid": "3imqGk1bDUKKEOxo5k_jow",
        "children": [
          {
            "id": "55",
            "parent": "54",
            "text": "Cribado",
            "guid": "aj-U6LELPkJJG5tA2s_R3Q",
            "children": [
              {
                "id": "56",
                "parent": "55",
                "text": "• NO se recomienda en asintomáticos (Recom. Fuerte)",
                "guid": "voAsKsC1s8pssJvTZkA_sw",
                "children": []
              }
            ]
          },
          {
            "id": "57",
            "parent": "54",
            "text": "Sospechar en:",
            "guid": "9egRsczfD8eKxe7CoD1GUQ",
            "children": [
              {
                "id": "58",
                "parent": "57",
                "text": "• Px sintomáticos con síntomas isquémicos retinales o hemisféricos (Recom. Condic.)",
                "guid": "OSwhFaoH8W29iqkJ7vgKpw",
                "children": []
              },
              {
                "id": "59",
                "parent": "57",
                "text": "• Px asintomáticos con soplo carotídeo, enf. coronaria o múltiples FR ateroscleróticos (Recom. Condic.)",
                "guid": "qC_3-7gWrRO4I7qwgDhbgA",
                "children": []
              }
            ]
          },
          {
            "id": "60",
            "parent": "54",
            "text": "Confirmación:",
            "guid": "BHLaBJgN_rY8OWts7gmMcg",
            "children": [
              {
                "id": "61",
                "parent": "60",
                "text": "• Eco-Doppler de carótidas → prueba inicial (Recom. Fuerte)",
                "guid": "gALFPon2Nt7J0WXb-NUooQ",
                "children": []
              },
              {
                "id": "62",
                "parent": "60",
                "text": "• MRA/CTA si eco no disponible o resultados equívocos (Recom. Fuerte);\nconsiderar si info adicional requerida (Recom. Condic.)",
                "guid": "HH1NJqaBQ6-fq3PDCKHtpA",
                "children": []
              },
              {
                "id": "63",
                "parent": "60",
                "text": "• Angiografía por catéter en sintomáticos seleccionados (Recom. Condic.)",
                "guid": "FI-5iA7yESrtpth-naWJ1w",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "64",
        "parent": "0",
        "text": "Manejo",
        "guid": "_Ti-sAVKT-ePzJIlN1AFXQ",
        "children": [
          {
            "id": "65",
            "parent": "64",
            "text": "Estenosis <50%",
            "guid": "JT2yBRjL2pXLKCjbNbV8Xw",
            "children": [
              {
                "id": "66",
                "parent": "65",
                "text": "• NO revascularizar (Recom. Fuerte)",
                "guid": "K1PGFqvONKAgMATprqrSuw",
                "children": []
              }
            ]
          },
          {
            "id": "67",
            "parent": "64",
            "text": "Px sintomáticos",
            "guid": "P523oLYnAN09kHbJgmjVnA",
            "children": [
              {
                "id": "68",
                "parent": "67",
                "text": "• Revascularización en 2 sem post-AIT/AVC si no hay contraindicaciones (Recom. Condic. )",
                "guid": "xr1anVus_pd0tQp0ZS2r-Q",
                "children": []
              },
              {
                "id": "69",
                "parent": "67",
                "text": "• 50%-99% estenosis + síntomas <6 meses + riesgo proced. muerte/AVC <6% → revascularizar",
                "guid": "s_Azd0DZWsqKcH46tkNRqA",
                "children": []
              },
              {
                "id": "70",
                "parent": "67",
                "text": "• CEA si 70%-99% (Recom. Fuerte)",
                "guid": "vBnusxyNP4ufGLF_kVkT7w",
                "children": []
              },
              {
                "id": "71",
                "parent": "67",
                "text": "• CEA si 50%-69% (Recom. Condic.)",
                "guid": "yWpWw44xykX_OJolQezUCA",
                "children": []
              },
              {
                "id": "72",
                "parent": "67",
                "text": "• CAS como alternativa si edad <70 años (Recom. Condic.)",
                "guid": "djA0lFiJts_H-lgEaYvztQ",
                "children": []
              },
              {
                "id": "73",
                "parent": "67",
                "text": "• Antiagregación: aspirina (75-325 mg/día) ó clopidogrel (75 mg/día) ó AAS/dipiridamol (25/200 mg 2v/d) (Recom. Fuerte)",
                "guid": "UwMIa3q39qqmpdwgVXRA-w",
                "children": []
              },
              {
                "id": "74",
                "parent": "67",
                "text": "• Control de HTA (Recom. Condic.), meta incierta",
                "guid": "pYBXogjMfBS_D3U7O29BIw",
                "children": []
              },
              {
                "id": "75",
                "parent": "67",
                "text": "• Estatinas para LDL <100 mg/dL (Recom. Fuerte); considerar ~70 mg/dL (Recom. Condic.)",
                "guid": "J6SfOdIOBHHfeB4BVUfBfg",
                "children": []
              }
            ]
          },
          {
            "id": "76",
            "parent": "64",
            "text": "Px asintomáticos\n(moderada-grave estenosis)",
            "guid": "MvhwVC3wyq56NCh1i-21ZA",
            "children": [
              {
                "id": "77",
                "parent": "76",
                "text": "• Control FR (HTA <140/90, LDL <100 mg/dL) (Recom. Fuerte)",
                "guid": "_z6X09mEuzVpZPq5b47TPg",
                "children": []
              },
              {
                "id": "78",
                "parent": "76",
                "text": "• Aspirina 75-325 mg/día (Recom. Condic.) (prevención IAM y otros beneficios CV; eficacia en prevención AVC no establecida)",
                "guid": "sVqx2-lj6RDowfGQQvddEg",
                "children": []
              },
              {
                "id": "79",
                "parent": "76",
                "text": "• Revascularizar solo en 60%-99% + ≥1 factor alto riesgo de AVC + riesgo proced. ≤3% + expectativa vida >5 años (Recom. Condic.)",
                "guid": "--rYaFWg0ILK4qpuVnUP8Q",
                "children": []
              },
              {
                "id": "80",
                "parent": "76",
                "text": "• CAS > CEA si riesgo qx alto y anatomía favorable (Recom. Condic.)",
                "guid": "hi_c2tBt3HtxftcH9PYv0w",
                "children": []
              },
              {
                "id": "81",
                "parent": "76",
                "text": "• NO revascularizar solo para prevenir deterioro cognitivo (Recom. Fuerte)",
                "guid": "0J4hG4UWFIceWf68_ioOug",
                "children": []
              }
            ]
          },
          {
            "id": "82",
            "parent": "64",
            "text": "Seguimiento",
            "guid": "LWefJHXvVLUnIwW4NcBhQg",
            "children": [
              {
                "id": "83",
                "parent": "82",
                "text": "• Eco-Doppler anual si >50% estenosis (Recom. Condic.)",
                "guid": "YMm5PQPFnTUN8e52O1ACHQ",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "84",
        "parent": "0",
        "text": "Historia y Examen Físico en\nEstenosis de la A. Carótida",
        "guid": "PLiphiaBEns2cHnk964HYQ",
        "children": [
          {
            "id": "85",
            "parent": "84",
            "text": "1. Presentación Clínica",
            "guid": "",
            "children": [
              {
                "id": "86",
                "parent": "85",
                "text": "• Asintomática",
                "guid": "kDn7iAA4OcdHkLZWuc6OdA",
                "children": [
                  {
                    "id": "87",
                    "parent": "86",
                    "text": "→ Hallazgo incidental (Eco por otro motivo / soplo carotídeo en examen físico)",
                    "guid": "VK8vEhl2drDgdDfFgwM2ug",
                    "children": []
                  }
                ]
              },
              {
                "id": "88",
                "parent": "85",
                "text": "• Sintomática\n(TIA o AVC)",
                "guid": "4lNszRfiz7Oj0Cu8r4nI-Q",
                "children": [
                  {
                    "id": "89",
                    "parent": "88",
                    "text": "→ Amaurosis fugaz, infarto retiniano",
                    "guid": "yTOnGAG2lLFSRdUn7DJI8A",
                    "children": []
                  },
                  {
                    "id": "90",
                    "parent": "88",
                    "text": "→ Debilidad o hipoestesia unilateral (cara, brazo, pierna)",
                    "guid": "IxhxlCQG7YBwx1w93rCWTw",
                    "children": []
                  },
                  {
                    "id": "91",
                    "parent": "88",
                    "text": "→ Hemianopsia homónima",
                    "guid": "psfUKRMM-akIJk6fAp-lqA",
                    "children": []
                  },
                  {
                    "id": "92",
                    "parent": "88",
                    "text": "→ Negligencia visuoespacial",
                    "guid": "48AjmoLfIsLHSdBxZjVsNw",
                    "children": []
                  },
                  {
                    "id": "93",
                    "parent": "88",
                    "text": "→ Afasia (expresiva, receptiva, mixta)",
                    "guid": "v8MD1b-mwbM5V33JWLYMZA",
                    "children": []
                  },
                  {
                    "id": "94",
                    "parent": "88",
                    "text": "→ Disartria (por parálisis facial)",
                    "guid": "I4T0I0wLVX_k9UxkAKsx_Q",
                    "children": []
                  },
                  {
                    "id": "95",
                    "parent": "88",
                    "text": "→ “Shaking TIA” (movimientos temblorosos transitorios)",
                    "guid": "0G2naIZFancvBnMnh3JdeA",
                    "children": []
                  },
                  {
                    "id": "96",
                    "parent": "88",
                    "text": "→ TIA “en crescendo” (episodios rápidos sucesivos)",
                    "guid": "XqDpKbsvy0YkNsfwUngaLg",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "97",
            "parent": "84",
            "text": "2. Historia",
            "guid": "SBpS4gIHR-GdMbTxxGFd-A",
            "children": [
              {
                "id": "98",
                "parent": "97",
                "text": "HPI (Historia de la\nEnfermedad Actual)",
                "guid": "XDsKT2J5Hz72j49NFLxaWQ",
                "children": [
                  {
                    "id": "99",
                    "parent": "98",
                    "text": "• Diferenciar síntomas transitorios vs persistentes (TIA vs AVC)",
                    "guid": "NwFxTI5V6agwZ_xRTVm8tw",
                    "children": []
                  },
                  {
                    "id": "100",
                    "parent": "98",
                    "text": "• Síntomas de posible disección (dolor ipsilateral en cuello/cara/cabeza)\n→ considerar <45 años o sin FR aterosclerosis",
                    "guid": "cUw5FJAQ-gC9o_29yY4U4A",
                    "children": []
                  }
                ]
              },
              {
                "id": "101",
                "parent": "97",
                "text": "PMH\n(Antecedentes)",
                "guid": "7wmnW0qEi3a7tnJhCyHwEg",
                "children": [
                  {
                    "id": "102",
                    "parent": "101",
                    "text": "• FR aterosclerosis: DM, HTA, Dislipidemia",
                    "guid": "n9_O2jMpnEWEzKYqJIQf9Q",
                    "children": []
                  },
                  {
                    "id": "103",
                    "parent": "101",
                    "text": "• Antecedente de TIA/AVC, IAM, CAD, PAD",
                    "guid": "xemEb_GnKGNp34ucSWs0jQ",
                    "children": []
                  },
                  {
                    "id": "104",
                    "parent": "101",
                    "text": "• Factores de disección: trauma de cuello, manipulación quiropráctica, enf. de tej. conectivo",
                    "guid": "s3Wq_J8VhL30SS-ICEI50g",
                    "children": []
                  },
                  {
                    "id": "105",
                    "parent": "101",
                    "text": "• Otras causas no ateroscleróticas: Takayasu, arteritis células gigantes, arteritis por radioterapia, displasia fibromuscular",
                    "guid": "3SYXqDX_uML4qfo8faOoOQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "106",
                "parent": "97",
                "text": "FH (Historia\nFamiliar)",
                "guid": "qwwqiaNhXNYgO13Gj9hklw",
                "children": [
                  {
                    "id": "107",
                    "parent": "106",
                    "text": "• Aterosclerosis en pariente <60 años",
                    "guid": "OkIeJDP_mqOm8Rsqjm4D6Q",
                    "children": []
                  },
                  {
                    "id": "108",
                    "parent": "106",
                    "text": "• AVC isquémico",
                    "guid": "lx-gJNpFccEXA_T67E211Q",
                    "children": []
                  },
                  {
                    "id": "109",
                    "parent": "106",
                    "text": "• Displasia fibromuscular",
                    "guid": "iokIlalPORmZqUDExMyUnw",
                    "children": []
                  },
                  {
                    "id": "110",
                    "parent": "106",
                    "text": "• Enf. de tej. conectivo",
                    "guid": "yS2tZ7j4nBId-GoJcwX2AQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "111",
                "parent": "97",
                "text": "SH (Historia\nSocial)",
                "guid": "cHqQGxN7qwRjFu78qKd0sQ",
                "children": [
                  {
                    "id": "112",
                    "parent": "111",
                    "text": "• Tabaquismo",
                    "guid": "KGp8oIPjCBJVzWIM8G4Biw",
                    "children": []
                  },
                  {
                    "id": "113",
                    "parent": "111",
                    "text": "• Ejercicio (prevención secundaria)",
                    "guid": "5lzLfXAz8JCD8b0INvDfBA",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "114",
            "parent": "84",
            "text": "3. Examen Físico",
            "guid": "f3Jd0QKtsZ25AZM1zuWsEQ",
            "children": [
              {
                "id": "115",
                "parent": "114",
                "text": "General",
                "guid": "IUcNoU3oHuZPoaQHeqoXVg",
                "children": [
                  {
                    "id": "116",
                    "parent": "115",
                    "text": "• PA",
                    "guid": "8eHyO950JDcQSEn3s8DuBQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "117",
                "parent": "114",
                "text": "Cuello",
                "guid": "1OH08HQI9hVwT2nqeHBi1g",
                "children": [
                  {
                    "id": "118",
                    "parent": "117",
                    "text": "• Soplo carotídeo (70%-89% en estrechamiento luminal de ~60%-70%)",
                    "guid": "sdJ0aO3OjsIcGmC-zoDo_Q",
                    "children": []
                  },
                  {
                    "id": "119",
                    "parent": "117",
                    "text": "• Hallazgo inespecífico (presente en 5% sin estenosis significativa)",
                    "guid": "u7lSfFojYyjKGqAyK8GZuQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "120",
                "parent": "114",
                "text": "Neuro",
                "guid": "bO3nrILBLGshK6c8BEv0pA",
                "children": [
                  {
                    "id": "121",
                    "parent": "120",
                    "text": "• Déficit motor/sensitivo contralateral a la lesión",
                    "guid": "CFBX677Qup0uRVT6PxxSAg",
                    "children": []
                  },
                  {
                    "id": "122",
                    "parent": "120",
                    "text": "• Alteraciones del habla, lenguaje o visión",
                    "guid": "qCq7-TEIb_86XIClLDS2Uw",
                    "children": []
                  },
                  {
                    "id": "123",
                    "parent": "120",
                    "text": "Diagnóstico de Estenosis de la A. Carótida",
                    "guid": "XZeA4iGF9KZ9omPKmspzTg",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "124",
        "parent": "0",
        "text": "A Quién Evaluar",
        "guid": "7Rii_qIjsmONtEbV5We0Zg",
        "children": [
          {
            "id": "125",
            "parent": "124",
            "text": "1.1) Sintomáticos",
            "guid": "XixqGXfjeIluR0vDa6erlg",
            "children": [
              {
                "id": "126",
                "parent": "125",
                "text": "• Sx retinianos/hemisféricos posibles isquémicos (Clase I, Nivel C)",
                "guid": "UZWdqjFh8UlPbUMnY4xkGQ",
                "children": []
              },
              {
                "id": "127",
                "parent": "125",
                "text": "• Síntomas focales en territorio de aCI izq/der (Clase I, Nivel C)",
                "guid": "fqCbNu-aEFguIOwLl289Hg",
                "children": []
              },
              {
                "id": "128",
                "parent": "125",
                "text": "• Síntomas neurol. inespec. si isquemia plausible (Clase IIb, Nivel C)",
                "guid": "SMAYQV1SgV03VpTHVOhAIg",
                "children": []
              }
            ]
          },
          {
            "id": "129",
            "parent": "124",
            "text": "1.2) Asintomáticos\n(considerar estudio si)",
            "guid": "-_CjYqfyJLM1YwlfoPiPWw",
            "children": [
              {
                "id": "130",
                "parent": "129",
                "text": "• Soplo carotídeo (IIa, C)",
                "guid": "J0pr1dX0Q1btacRF420pPw",
                "children": []
              },
              {
                "id": "131",
                "parent": "129",
                "text": "• PAD sintomática (IIb, C)",
                "guid": "hQOsRosPb16hP_cQ9AtEvw",
                "children": []
              },
              {
                "id": "132",
                "parent": "129",
                "text": "• CAD (IIb, C)",
                "guid": "wg915tdZpuyv7rqxtyO1WA",
                "children": []
              },
              {
                "id": "133",
                "parent": "129",
                "text": "• Aneurisma aórtico aterosclerótico (IIb, C)",
                "guid": "GDrO1BfQ8YCvVKpG4YvAvA",
                "children": []
              },
              {
                "id": "134",
                "parent": "129",
                "text": "• Sin evidencia de aterosclerosis + ≥2 FR (HTA, Hiperlipidemia, Tabaco, HF1° <60 años, HF AVC)",
                "guid": "9jtf3rdTp0LgcYwgPghZCQ",
                "children": []
              },
              {
                "id": "135",
                "parent": "129",
                "text": "• Pre-CABG (electiva o urgente)",
                "guid": "LCX6JHs5SHp-H1OnF5xpbw",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "136",
        "parent": "0",
        "text": "2. Modalidades\nde Imagen",
        "guid": "t2Exfrx5JX_c8cPVgZ8CdQ",
        "children": [
          {
            "id": "137",
            "parent": "136",
            "text": "2.1) Eco-Doppler Carotídeo",
            "guid": "uJnmU8BXFO1UgE4ki4lsQA",
            "children": [
              {
                "id": "138",
                "parent": "137",
                "text": "• Prueba inicial en mayoría (Clase I, Nivel C)",
                "guid": "nTv0mh8Lr1ZlywAhCcL5Wg",
                "children": []
              }
            ]
          },
          {
            "id": "139",
            "parent": "136",
            "text": "2.2) MRA/CTA",
            "guid": "4GKFOXje3IemGBJpz9erLQ",
            "children": [
              {
                "id": "140",
                "parent": "139",
                "text": "• Si Eco no disponible o resultados equívocos (Clase I, Nivel C)",
                "guid": "ZSh9TxapaopAKTlikCgEdA",
                "children": []
              },
              {
                "id": "141",
                "parent": "139",
                "text": "• MRA: puede sobreestimar estenosis",
                "guid": "Ccbx1Y322r47YyPa7NL-RA",
                "children": []
              },
              {
                "id": "142",
                "parent": "139",
                "text": "• CTA: problemas si calcificaciones severas",
                "guid": "zqTQeSwr2Ov47ffi7ooRNA",
                "children": []
              },
              {
                "id": "143",
                "parent": "139",
                "text": "• Dificultad en diferenciar estenosis subtotal vs oclusión total",
                "guid": "KbzLOpaWempTF2szwJR-DA",
                "children": []
              }
            ]
          },
          {
            "id": "144",
            "parent": "136",
            "text": "2.3) Angiografía\npor Catéter",
            "guid": "WUvA3djNYWbSFeHo6IFeaQ",
            "children": [
              {
                "id": "145",
                "parent": "144",
                "text": "• Seleccionar px sintomáticos → si pruebas no invasivas\ninconcluyentes o se requiere detalle anatómico adicional",
                "guid": "J9ilycxqRreC0zMfV2TPUg",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "146",
        "parent": "0",
        "text": "3. Severidad de Estenosis",
        "guid": "HFVVcEfN-oSJyB65B9ydtg",
        "children": [
          {
            "id": "147",
            "parent": "146",
            "text": "• Moderada: 50%-69%",
            "guid": "MRb8LvaGYbphsqFcE31Eng",
            "children": []
          },
          {
            "id": "148",
            "parent": "146",
            "text": "• Severa: 70%-99%",
            "guid": "Ek8eRkcNG4mwvQ7RqMHWGQ",
            "children": []
          }
        ]
      },
      {
        "id": "149",
        "parent": "0",
        "text": "4. Diagnóstico Diferencial\n(Soplo Carotídeo)",
        "guid": "o_aFnN8IGa-e5Oto9vmG4w",
        "children": [
          {
            "id": "150",
            "parent": "149",
            "text": "• Soplo cardíaco referido (p.ej. insuf. mitral/aórtica)",
            "guid": "OfnHQBb8k3mi6XR1umA-9A",
            "children": []
          },
          {
            "id": "151",
            "parent": "149",
            "text": "• Hum venoso carotídeo (↑gasto: anemia, tirotoxicosis, embarazo, cirrosis, fístula AV, malformación AV)",
            "guid": "YU3KRRdW-sKYqb_lO0xTNg",
            "children": []
          },
          {
            "id": "152",
            "parent": "149",
            "text": "• Obstrucción a. subclavia izq",
            "guid": "nB90fD8QAMbwXIoKU9Kg_g",
            "children": []
          },
          {
            "id": "153",
            "parent": "149",
            "text": "• Obstrucción vertebrobasilar",
            "guid": "7kdwQVreZh40rZ7VKtEb2g",
            "children": []
          }
        ]
      },
      {
        "id": "154",
        "parent": "0",
        "text": "5. Otras Causas de\nTIA/AVC Semelhantes",
        "guid": "pjixBdlnRRtY56E3ETV_EA",
        "children": [
          {
            "id": "155",
            "parent": "154",
            "text": "• Aterosclerosis intracraneal",
            "guid": "bkwx08ukGpby0B9BMjnlWQ",
            "children": []
          },
          {
            "id": "156",
            "parent": "154",
            "text": "• Pequeños vasos",
            "guid": "DfkESjyLa912CVbxgWewMw",
            "children": []
          },
          {
            "id": "157",
            "parent": "154",
            "text": "• Émbolos cardíacos",
            "guid": "NdVZD65ik436eKAUshNyPA",
            "children": []
          }
        ]
      },
      {
        "id": "158",
        "parent": "0",
        "text": "6. Resumen de Pruebas",
        "guid": "FcBx1kqLkDHwTHy-Rlhbgg",
        "children": [
          {
            "id": "159",
            "parent": "158",
            "text": "6.1) Sintomáticos",
            "guid": "sO6AKZ-fMyjMoKk2EVHKbw",
            "children": [
              {
                "id": "160",
                "parent": "159",
                "text": "• Eco-Doppler → prueba inicial (I, C)",
                "guid": "g-PF7bZPBlKMGCoyOy1Wdg",
                "children": []
              },
              {
                "id": "161",
                "parent": "159",
                "text": "• MRA/CTA → si Eco no es posible o equívoco (I, C)",
                "guid": "R5T7ugYSmnO8b5nv2-sMng",
                "children": []
              },
              {
                "id": "162",
                "parent": "159",
                "text": "• Angiografía → si imágenes no conclusivas o se requiere detalle extra",
                "guid": "Hl22jAAY6kITQ8eLlzrwkQ",
                "children": []
              }
            ]
          },
          {
            "id": "163",
            "parent": "158",
            "text": "6.2) Asintomáticos",
            "guid": "1QK9W2nfK6wmyx7OIMc5qQ",
            "children": [
              {
                "id": "164",
                "parent": "163",
                "text": "• Eco-Doppler → si soplo, PAD, CAD, aneurisma aórtico, o ≥2 FR ateroscl. (IIb, C)",
                "guid": "H1RImv0NCj7gU4tdoA6x5Q",
                "children": []
              },
              {
                "id": "165",
                "parent": "163",
                "text": "• Objetivo: detectar estenosis hemodinám. significativa",
                "guid": "u0QbMuFYP2vQFyuKNiwTdg",
                "children": []
              },
              {
                "id": "166",
                "parent": "163",
                "text": "Estudios de Imagen en Estenosis de la A. Carótida",
                "guid": "ipNWmh0nK_tro4rmvhRuXQ",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "167",
        "parent": "0",
        "text": "1. Consideraciones\nGenerales",
        "guid": "deTMpNjVwqh90ZpegVxBDw",
        "children": [
          {
            "id": "168",
            "parent": "167",
            "text": "• Evaluación no invasiva (Eco-Doppler, MRA, CTA) recomendada como 1ra opción en px con síntomas retinianos/hemisféricos isquémicos\n(ASA/ACCF/AHA Clase I, Nivel C)",
            "guid": "LZkTUDB-McgMRffrBICv7Q",
            "children": []
          },
          {
            "id": "169",
            "parent": "167",
            "text": "• Determinar % de estenosis es clave (método +común: NASCET)",
            "guid": "j3ip9yeFdmjqqjHzZ-vFeQ",
            "children": []
          }
        ]
      },
      {
        "id": "170",
        "parent": "0",
        "text": "2. Métodos para\nMedir la Estenosis",
        "guid": "vZEiHSw5lpF4NswW7fi0Vg",
        "children": [
          {
            "id": "171",
            "parent": "170",
            "text": "2.1) NASCET",
            "guid": "5XktRv4SCYkZKqe0z-II1Q",
            "children": [
              {
                "id": "172",
                "parent": "171",
                "text": "• %E = [1 - (diámetro de la zona +estrecha / diámetro de a. normal distal bif.)] x 100",
                "guid": "ZrV_fW2e86IY9QBvuxXEpg",
                "children": []
              }
            ]
          },
          {
            "id": "173",
            "parent": "170",
            "text": "2.2) ECST",
            "guid": "XQz0M9YJ7jE2G840szAmig",
            "children": [
              {
                "id": "174",
                "parent": "173",
                "text": "• %E = [1 - (diámetro de la zona +estrecha / diámetro original estimado en el mismo sitio)] x 100",
                "guid": "wBHz9v71i_lv85TSDKYRPw",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "175",
        "parent": "0",
        "text": "3. Modalidades\nde Imagen",
        "guid": "wTWVmijfpuYYMs2-ISaf4g",
        "children": [
          {
            "id": "176",
            "parent": "175",
            "text": "3.1) Eco-Doppler Carotídeo",
            "guid": "njarEq7_SqrORojjyGCvDg",
            "children": [
              {
                "id": "177",
                "parent": "176",
                "text": "• Mide velocidades sistólicas pico → estima % estenosis",
                "guid": "5n71Tjo3QISwwI3HNsyK2Q",
                "children": []
              },
              {
                "id": "178",
                "parent": "176",
                "text": "• Ventajas: no invasivo, amplio uso",
                "guid": "ZmabSESP2W2SUNus_zPJ7g",
                "children": []
              }
            ]
          },
          {
            "id": "179",
            "parent": "175",
            "text": "3.2) MRA/CTA",
            "guid": "zI2pC_6OTPkoqsyw5C8wug",
            "children": [
              {
                "id": "180",
                "parent": "179",
                "text": "• Visualizan estrechamiento luminal",
                "guid": "d7SZ6k3ykambXy914aLlOA",
                "children": []
              },
              {
                "id": "181",
                "parent": "179",
                "text": "• Limitaciones: MRA sobrestima estenosis + difícil distinguir subtotal vs oclusión total; CTA menos precisa en lesiones muy calcificadas",
                "guid": "JT_MOFsC92lzpduDikvPMQ",
                "children": []
              }
            ]
          },
          {
            "id": "182",
            "parent": "175",
            "text": "3.3) Angiografía\nCerebral (Catéter)",
            "guid": "_dvuGgYzguEDtnkkwYdLAA",
            "children": [
              {
                "id": "183",
                "parent": "182",
                "text": "• Opción en casos sintomáticos selectos → cuando resultados no\ninvasivos son inconclusos o se requiere detalle anatómico",
                "guid": "UVgMWLRom01pCijz9NhnTw",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "184",
        "parent": "0",
        "text": "4. Información Adicional que\nBrindan las Imágenes",
        "guid": "qJZ20M021XVYSmcUd2dE2A",
        "children": [
          {
            "id": "185",
            "parent": "184",
            "text": "• Ubicación de la bifurcación (en relación al ángulo mandibular)",
            "guid": "L6cQZXdzMKyStR97OvnExw",
            "children": []
          },
          {
            "id": "186",
            "parent": "184",
            "text": "• Cantidad de placa",
            "guid": "H1nmyfZM2kFv_Me2oAYtwg",
            "children": []
          },
          {
            "id": "187",
            "parent": "184",
            "text": "• Tortuosidad distal / estenosis adicional",
            "guid": "JDKq8P030tE52KsepxuGUw",
            "children": []
          },
          {
            "id": "188",
            "parent": "184",
            "text": "• Estado de la carótida contralateral y circulación colateral",
            "guid": "rRhJdiWReEtYKaQ8-8VfcA",
            "children": []
          },
          {
            "id": "189",
            "parent": "184",
            "text": "• Diferenciar aterosclerosis de otras patologías (disección, FMD, etc.)",
            "guid": "b-WWpeHzoURS6aVtf4pnLg",
            "children": []
          }
        ]
      },
      {
        "id": "190",
        "parent": "0",
        "text": "Ultrasonografía (Eco-Doppler) en\nEstenosis de la A. Carótida",
        "guid": "mPBZMz5RZLBOBJLSYYanIg",
        "children": [
          {
            "id": "191",
            "parent": "190",
            "text": "1. Fundamento",
            "guid": "",
            "children": [
              {
                "id": "192",
                "parent": "191",
                "text": "• Mide la velocidad del flujo (especialmente PSV) → indicador de severidad de estenosis",
                "guid": "DJuILl6eayjTWFo_Kx5e7w",
                "children": []
              },
              {
                "id": "193",
                "parent": "191",
                "text": "• Primer estudio recomendado en px con sospecha/enfermedad conocida de a. carótida\n(ASA/ACCF/AHA Clase I, Nivel C)",
                "guid": "jHPpsrTp6CiOvApl5OpmNw",
                "children": []
              }
            ]
          },
          {
            "id": "194",
            "parent": "190",
            "text": "2. Recomendaciones Principales\n(ASA/ACCF/AHA)",
            "guid": "JHeu8Cz3TLiFN8mUBsj4jQ",
            "children": [
              {
                "id": "195",
                "parent": "194",
                "text": "2.1) Asintomáticos",
                "guid": "7bKXW93l14lC5jhPP_L3qg",
                "children": [
                  {
                    "id": "196",
                    "parent": "195",
                    "text": "• Eco-Doppler (laboratorio calificado) como 1er test para detectar estenosis hemodinám. significativa (Clase I, C)",
                    "guid": "hNpKrEAqyobMNwcyK8rmag",
                    "children": []
                  },
                  {
                    "id": "197",
                    "parent": "195",
                    "text": "• Razonable si soplo carotídeo (IIa, C)",
                    "guid": "N0P1LqTMeZaxsSshLWNOwA",
                    "children": []
                  },
                  {
                    "id": "198",
                    "parent": "195",
                    "text": "• Considerar si PAD sintomática, CAD, aneurisma aórtico aterosclerótico o ≥2 FR\n(HTA, hiperlipidemia, tabaquismo, HF1° <60 años, HF AVC) (IIb, C)",
                    "guid": "SzsJtsguUwVb2mgdUu8pfw",
                    "children": []
                  }
                ]
              },
              {
                "id": "199",
                "parent": "194",
                "text": "2.2) Sintomáticos",
                "guid": "UKpgKTnNX_uF63YjDBjVBQ",
                "children": [
                  {
                    "id": "200",
                    "parent": "199",
                    "text": "• Eco-Doppler si síntomas neurol. focales en territorio de\na. carótida interna (I, C)",
                    "guid": "as_c2C__d8m7ifwUGBIv9A",
                    "children": []
                  },
                  {
                    "id": "201",
                    "parent": "199",
                    "text": "• Considerar si síntomas neurol. inespecíficos\nplausibles de isquemia (IIb, C)",
                    "guid": "gUqhdAY7xK3Vzj0X7KFylw",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "202",
            "parent": "190",
            "text": "3. Guías ESVS",
            "guid": "Lv80n_9X6hjwCSg5IjGcUQ",
            "children": [
              {
                "id": "203",
                "parent": "202",
                "text": "• Para definir alcance/grado de estenosis:\nusar Eco, CTA y/o MRA (Clase I, B)",
                "guid": "TS_OBsY1KiqItQDwHa0xew",
                "children": []
              },
              {
                "id": "204",
                "parent": "202",
                "text": "• Antes de endarterectomía: corroborar hallazgo con\nCTA/MRA o repetir Eco (otro operador) (I, B)",
                "guid": "4J-4OT_TSD9t9YJmYU5bkw",
                "children": []
              },
              {
                "id": "205",
                "parent": "202",
                "text": "• Reportar el método de medición usado (I, C)",
                "guid": "miXK2H9Br3x_Ddmot3_mag",
                "children": []
              }
            ]
          },
          {
            "id": "206",
            "parent": "190",
            "text": "4. Clasificación de Estenosis\n(Sociedad de Radiólogos en\nUltrasonido)",
            "guid": "fzzO1Yg2evwGaCIn8mI4NA",
            "children": [
              {
                "id": "207",
                "parent": "206",
                "text": "• <50%: PSV ≤125 cm/s + placa/intima engrosada",
                "guid": "co5SIlyx3EekU5sQ6Wey5g",
                "children": []
              },
              {
                "id": "208",
                "parent": "206",
                "text": "• 50%-69%: PSV 125-230 cm/s + placa visible",
                "guid": "oi2jeou7n_lfhQLQnIfsxA",
                "children": []
              },
              {
                "id": "209",
                "parent": "206",
                "text": "• ≥70%-cerca de oclusión: PSV >230 cm/s + placa + lumen reducido",
                "guid": "-nZpG5Ngtke6ny8DsfecCg",
                "children": []
              },
              {
                "id": "210",
                "parent": "206",
                "text": "• Casi oclusión: lumen muy estrechado (color Doppler)",
                "guid": "F4RS6oL_cmHGHdnVWgGOqg",
                "children": []
              },
              {
                "id": "211",
                "parent": "206",
                "text": "• Oclusión total: sin lumen ni flujo detectable (grayscale, spectral, power, color)",
                "guid": "7oKFtfDijN7iFUts74UPUw",
                "children": []
              }
            ]
          },
          {
            "id": "212",
            "parent": "190",
            "text": "5. Hallazgos Adicionales\n(estudios y valores de corte)",
            "guid": "DGyLXtSIvdapPmGHmJATaw",
            "children": [
              {
                "id": "213",
                "parent": "212",
                "text": "• PSV ≥250 cm/s y EDV ≥60 cm/s → alta S y E para detectar >60% estenosis (J Vasc Surg 2014)",
                "guid": "wHFrTAdiSuzrVrVPTyWIqg",
                "children": []
              },
              {
                "id": "214",
                "parent": "212",
                "text": "• Sombra acústica (calcificación extensa) → puede subestimar severidad de la estenosis",
                "guid": "24dz7mu4UGAbxZMQw7fNDg",
                "children": []
              },
              {
                "id": "215",
                "parent": "212",
                "text": "• Eco con contraste → sensibilidad moderada, especificidad baja para úlceras de placa",
                "guid": "wH0vknHHr1-aV3zRaQ4f8Q",
                "children": []
              }
            ]
          }
        ]
      },
      {
        "id": "216",
        "parent": "0",
        "text": "MRA y CTA en Estenosis\nde la A. Carótida",
        "guid": "3shiqTzGacZ8Lmz50ypI0w",
        "children": [
          {
            "id": "217",
            "parent": "216",
            "text": "1. Recomendaciones\nASA/ACCF/AHA",
            "guid": "",
            "children": [
              {
                "id": "218",
                "parent": "217",
                "text": "1.1) Indicaciones",
                "guid": "n4wjB_-IBGzgOl1GKWi0ow",
                "children": [
                  {
                    "id": "219",
                    "parent": "218",
                    "text": "• MRA/CTA si síntomas focales isquémicos en territorio de la aCI y Eco no disponible o equívoco (I, C)",
                    "guid": "n7yh9H6eYqQcLSL8RepXYQ",
                    "children": []
                  },
                  {
                    "id": "220",
                    "parent": "218",
                    "text": "• MRA/CTA si se considera revascularización y Eco es equívoco/indeterminado (IIa, C)",
                    "guid": "k3UrBggczr0G_GQGvDt8-A",
                    "children": []
                  },
                  {
                    "id": "221",
                    "parent": "218",
                    "text": "• MRA/CTA si síntomas retinianos/hemisféricos sin fuente extracraneal identificada → evaluar vasos intracraneales (IIa, C)",
                    "guid": "N4oTROIqaBZXyJ75zPfi2w",
                    "children": []
                  },
                  {
                    "id": "222",
                    "parent": "218",
                    "text": "• MRA/CTA antes de intervención, para precisar estenosis y lesiones\nintratorácicas/intracraneales no evaluadas en Eco (IIa, C)",
                    "guid": "emPNsg4B2zlZfJ93z4vKSg",
                    "children": []
                  }
                ]
              },
              {
                "id": "223",
                "parent": "217",
                "text": "1.2) Situaciones\nEspecíficas",
                "guid": "prsS6YkdzVXa9shNXk8lnQ",
                "children": [
                  {
                    "id": "224",
                    "parent": "223",
                    "text": "• MRA sin contraste razonable en px con enfermedad carotídea sintomática\ny disfunción renal o calcificación extensa (IIa, C)",
                    "guid": "xBeCGXlJt5klWu2ExvBcKQ",
                    "children": []
                  },
                  {
                    "id": "225",
                    "parent": "223",
                    "text": "• CTA razonable si no apto para MRA\n(claustrofobia, marcapasos, etc.) (IIa, C)",
                    "guid": "SKC3fjgZ6m_2lqiPadKe1w",
                    "children": []
                  },
                  {
                    "id": "226",
                    "parent": "223",
                    "text": "• Usar sistemas MRI de alta calidad,\nevitar sistemas de bajo campo (IIa, C)",
                    "guid": "AKsArPOL1c11FzcXvVWR3w",
                    "children": []
                  }
                ]
              }
            ]
          },
          {
            "id": "227",
            "parent": "216",
            "text": "2. Recomendaciones\nESVS",
            "guid": "EZT3NVRnpqiP0i5gTRkykQ",
            "children": [
              {
                "id": "228",
                "parent": "227",
                "text": "2.1) Evaluación\nde Estenosis",
                "guid": "4F_tNbOmr7S8usns36RS5w",
                "children": [
                  {
                    "id": "229",
                    "parent": "228",
                    "text": "• Duplex, CTA y/o MRA para definir grado\nde estenosis extracraneal (I, B)",
                    "guid": "AtLcfki4omDd5eaKTsUfag",
                    "children": []
                  }
                ]
              },
              {
                "id": "230",
                "parent": "227",
                "text": "2.2)\nPre-Endarterectomía",
                "guid": "hOk-zEjrMP645NkEexSH2A",
                "children": [
                  {
                    "id": "231",
                    "parent": "230",
                    "text": "• Confirmar grado de estenosis\n(Eco) con CTA/MRA o repetir Eco\ncon otro operador (I, B)",
                    "guid": "jXMUeMRuB9K54iQVTJ3DUQ",
                    "children": []
                  }
                ]
              },
              {
                "id": "232",
                "parent": "227",
                "text": "2.3) Pre-Stent",
                "guid": "kP7j1jxSLzPug_BI2-Cqzw",
                "children": [
                  {
                    "id": "233",
                    "parent": "232",
                    "text": "• Realizar CTA/MRA tras Eco → evalúa arco\naórtico + circulación extra/intracraneal (I, B)",
                    "guid": "TvKpgvYHb0C1SRbo6uuYFg",
                    "children": []
                  }
                ]
              }
            ]
          }
        ]
      },
      {
        "id": "234",
        "parent": "0",
        "text": "MRA en Estenosis\nde la A. Carótida",
        "guid": "aF_ZkktU0pmnb-q0d2rxRA",
        "children": [
          {
            "id": "235",
            "parent": "234",
            "text": "1. Ventajas",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "236",
        "parent": "0",
        "text": "• Insensible a calcificaciones (a\ndiferencia de US/CTA)",
        "guid": "txoAIGRk4rDo8bU4BhxC5Q",
        "children": []
      },
      {
        "id": "237",
        "parent": "0",
        "text": "• Gadolinio (contraste) → menor\nnefrotoxicidad y reacciones alérgicas\nque el contraste iodado",
        "guid": "",
        "children": [
          {
            "id": "238",
            "parent": "237",
            "text": "2. Limitaciones",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "239",
        "parent": "0",
        "text": "• Puede\nsobreestimar la\nestenosis",
        "guid": "",
        "children": []
      },
      {
        "id": "240",
        "parent": "0",
        "text": "• Dificultad para diferenciar estenosis\nsubtotal vs oclusión total",
        "guid": "",
        "children": []
      },
      {
        "id": "241",
        "parent": "0",
        "text": "• No apto en px con claustrofobia,\nobesidad extrema o implantes\nmetálicos no compatibles",
        "guid": "",
        "children": []
      },
      {
        "id": "242",
        "parent": "0",
        "text": "• Gadolinio en altas dosis → riesgo\nde fibrosis sistémica nefrogénica\nen disfunción renal",
        "guid": "",
        "children": [
          {
            "id": "243",
            "parent": "242",
            "text": "3. Evidencia\n(Revisiones\nSistemáticas)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "244",
        "parent": "0",
        "text": "• Sensibilidad ~95% y\nespecificidad ~90% para\nestenosis ≥70% (varios\nestudios)",
        "guid": "",
        "children": []
      },
      {
        "id": "245",
        "parent": "0",
        "text": "• Excelente para oclusión (casi\n98%-100% de exactitud)",
        "guid": "",
        "children": []
      },
      {
        "id": "246",
        "parent": "0",
        "text": "• Menor sensibilidad para\nestenosis 50%-69% (ej. ~66%\nen MRA con contraste)",
        "guid": "",
        "children": [
          {
            "id": "247",
            "parent": "246",
            "text": "4. Recomendaciones\nGenerales",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "248",
        "parent": "0",
        "text": "• MRA contrastada = buena\nopción para detectar estenosis\nseveras (70%-99%)",
        "guid": "",
        "children": []
      },
      {
        "id": "249",
        "parent": "0",
        "text": "• Usar como complemento si Eco es\nequívoco o se requiere evaluación\nanatómica detallada",
        "guid": "",
        "children": []
      },
      {
        "id": "250",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "251",
        "parent": "0",
        "text": "CTA en Estenosis de\nla A. Carótida",
        "guid": "Zheuiqw7LYzHMBj4ggkfyg",
        "children": [
          {
            "id": "252",
            "parent": "251",
            "text": "1. Ventajas",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "253",
        "parent": "0",
        "text": "• Imágenes directas del lumen arterial →\nevaluación precisa de estenosis",
        "guid": "",
        "children": []
      },
      {
        "id": "254",
        "parent": "0",
        "text": "• Buena resolución de\ntodo el árbol vascular",
        "guid": "",
        "children": []
      },
      {
        "id": "255",
        "parent": "0",
        "text": "• Comparación favorable con\nangiografía por catéter",
        "guid": "",
        "children": []
      },
      {
        "id": "256",
        "parent": "0",
        "text": "• Amplia\ndisponibilidad y\nrapidez",
        "guid": "",
        "children": [
          {
            "id": "257",
            "parent": "256",
            "text": "2. Limitaciones",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "258",
        "parent": "0",
        "text": "• Lesiones calcificadas → difícil\ncuantificar estenosis",
        "guid": "",
        "children": []
      },
      {
        "id": "259",
        "parent": "0",
        "text": "• Problemas para diferenciar\nestenosis subtotal vs oclusión total",
        "guid": "",
        "children": []
      },
      {
        "id": "260",
        "parent": "0",
        "text": "• Implantes metálicos pueden\nocultar arterias cervicales",
        "guid": "",
        "children": []
      },
      {
        "id": "261",
        "parent": "0",
        "text": "• Obesidad o movimientos del px →\ndificultan la exploración",
        "guid": "",
        "children": []
      },
      {
        "id": "262",
        "parent": "0",
        "text": "• Riesgo de nefrotoxicidad con\ncontraste iodado → evitar en\ndisfunción renal",
        "guid": "",
        "children": [
          {
            "id": "263",
            "parent": "262",
            "text": "3. Evidencia\n(Revisiones\nSistemáticas)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "264",
        "parent": "0",
        "text": "3.1) Estenosis 70%-99%",
        "guid": "",
        "children": []
      },
      {
        "id": "265",
        "parent": "0",
        "text": "• Sensibilidad ~65%-77%",
        "guid": "",
        "children": []
      },
      {
        "id": "266",
        "parent": "0",
        "text": "• Especificidad\n~56%-95%",
        "guid": "",
        "children": []
      },
      {
        "id": "267",
        "parent": "0",
        "text": "3.2) Estenosis 50%-69%",
        "guid": "",
        "children": []
      },
      {
        "id": "268",
        "parent": "0",
        "text": "• Sensibilidad ~41%-67%",
        "guid": "",
        "children": []
      },
      {
        "id": "269",
        "parent": "0",
        "text": "• Especificidad\n~79%-84%",
        "guid": "",
        "children": []
      },
      {
        "id": "270",
        "parent": "0",
        "text": "• Amplio rango por heterogeneidad y\nposibles sesgos de publicación",
        "guid": "",
        "children": []
      },
      {
        "id": "271",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "272",
        "parent": "0",
        "text": "Angiografía (catéter)",
        "guid": "DuAlUXno--X8Uc-t7-T9RQ",
        "children": [
          {
            "id": "273",
            "parent": "272",
            "text": "1. Generalidades",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "274",
        "parent": "0",
        "text": "• Procedimiento invasivo con\ninyección de contraste",
        "guid": "",
        "children": []
      },
      {
        "id": "275",
        "parent": "0",
        "text": "• Riesgo 0.5%-1%: AVC, IAM, lesión\narterial, lesión retroperitoneal",
        "guid": "",
        "children": [
          {
            "id": "276",
            "parent": "275",
            "text": "2. Recomendaciones\n(ASA/ACCF/AHA)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "277",
        "parent": "0",
        "text": "2.1) Clase IIa, Nivel C",
        "guid": "",
        "children": []
      },
      {
        "id": "278",
        "parent": "0",
        "text": "• Si no se identifica fuente\nextracraneal de isquemia y persisten\nsíntomas retinianos/hemisféricos",
        "guid": "",
        "children": []
      },
      {
        "id": "279",
        "parent": "0",
        "text": "• Para evaluar severidad de estenosis y\nlesiones intratorácicas/intracraneales si\nse planea intervención",
        "guid": "",
        "children": []
      },
      {
        "id": "280",
        "parent": "0",
        "text": "Angiografía (catéter)",
        "guid": "",
        "children": [
          {
            "id": "281",
            "parent": "280",
            "text": "1. Generalidades",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "282",
        "parent": "0",
        "text": "• Procedimiento invasivo con\ninyección de contraste",
        "guid": "",
        "children": []
      },
      {
        "id": "283",
        "parent": "0",
        "text": "• Riesgo 0.5%-1%: AVC, IAM, lesión\narterial, lesión retroperitoneal",
        "guid": "",
        "children": [
          {
            "id": "284",
            "parent": "283",
            "text": "2. Recomendaciones\n(ASA/ACCF/AHA)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "285",
        "parent": "0",
        "text": "2.1) Clase IIa, Nivel C",
        "guid": "",
        "children": []
      },
      {
        "id": "286",
        "parent": "0",
        "text": "• Si no se identifica fuente\nextracraneal de isquemia y persisten\nsíntomas retinianos/hemisféricos",
        "guid": "",
        "children": []
      },
      {
        "id": "287",
        "parent": "0",
        "text": "• Para evaluar severidad de estenosis y lesiones\nintratorácicas/intracraneales si se planea intervención\n(estenosis significativa detectada por Eco)",
        "guid": "",
        "children": []
      },
      {
        "id": "288",
        "parent": "0",
        "text": "• Cuando estudios no\ninvasivos son inconsistentes,\ninconclusos o inviables",
        "guid": "",
        "children": []
      },
      {
        "id": "289",
        "parent": "0",
        "text": "2.2) Clase IIb, Nivel C",
        "guid": "",
        "children": []
      },
      {
        "id": "290",
        "parent": "0",
        "text": "• Si se sugiere oclusión total en\nEco/MRA/CTA y se quiere confirmar\npermeabilidad suficiente para revascularizar",
        "guid": "",
        "children": []
      },
      {
        "id": "291",
        "parent": "0",
        "text": "• En px con disfunción renal →\nlimitar volumen de contraste si se\nevalúa un solo territorio",
        "guid": "",
        "children": [
          {
            "id": "292",
            "parent": "291",
            "text": "3. Recomendación ESVS",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "293",
        "parent": "0",
        "text": "• No usar angiografía IA de rutina para decidir\nrevascularización a menos que existan discrepancias\nimportantes en estudios no invasivos (Clase III, B)",
        "guid": "",
        "children": []
      },
      {
        "id": "294",
        "parent": "0",
        "text": "Ecocardiografía",
        "guid": "",
        "children": [
          {
            "id": "295",
            "parent": "294",
            "text": "1. Recomendación\n(ASA/ACCF/AHA Clase I, Nivel\nC)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "296",
        "parent": "0",
        "text": "• Realizar en búsqueda de fuente\ncardioembólica cuando la enfermedad\nextra/intracraneal no explica los síntomas\nneurológicos sospechosos de origen isquémico",
        "guid": "",
        "children": []
      },
      {
        "id": "297",
        "parent": "0",
        "text": "Manejo de la Estenosis\nde la A. Carótida",
        "guid": "25cDKjMxX7EIUW0ixwMRuQ",
        "children": [
          {
            "id": "298",
            "parent": "297",
            "text": "1. Visión General",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "299",
        "parent": "0",
        "text": "• <50% de estenosis →\nNO revascularizar",
        "guid": "",
        "children": []
      },
      {
        "id": "300",
        "parent": "0",
        "text": "• Px sintomáticos (50%-99% + síntomas\n≤6 meses + riesgo proc. <6%)",
        "guid": "",
        "children": []
      },
      {
        "id": "301",
        "parent": "0",
        "text": "→ Considerar revascularizar\nen las 2 sem post-AIT/AVC si\nno hay contraind.",
        "guid": "",
        "children": []
      },
      {
        "id": "302",
        "parent": "0",
        "text": "→ CEA si 70%-99%",
        "guid": "",
        "children": []
      },
      {
        "id": "303",
        "parent": "0",
        "text": "→ CEA opcional\nsi 50%-69%",
        "guid": "",
        "children": []
      },
      {
        "id": "304",
        "parent": "0",
        "text": "→ CAS\nalternativa si <70\naños",
        "guid": "",
        "children": []
      },
      {
        "id": "305",
        "parent": "0",
        "text": "• Terapia\nmédica\nadyuvante",
        "guid": "",
        "children": []
      },
      {
        "id": "306",
        "parent": "0",
        "text": "→ Antiagregante (AAS 75-325 mg/día\no Clopidogrel 75 mg/día o\nAAS/dipiridamol 25/200 mg 2v/d)",
        "guid": "",
        "children": []
      },
      {
        "id": "307",
        "parent": "0",
        "text": "→ Control TA (meta no establecida,\n<140/90 en asintomáticos)",
        "guid": "",
        "children": []
      },
      {
        "id": "308",
        "parent": "0",
        "text": "→ Estatinas (LDL <100 mg/dL;\nconsiderar ~70 mg/dL)",
        "guid": "",
        "children": [
          {
            "id": "309",
            "parent": "308",
            "text": "2. Px Asintomáticos\n(estenosis moderada-grave)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "310",
        "parent": "0",
        "text": "• Control FR (HTA <140/90, LDL <100\nmg/dL), cambios de estilo de vida",
        "guid": "",
        "children": []
      },
      {
        "id": "311",
        "parent": "0",
        "text": "• Aspirina 75-325 mg/día →\nPrevención IAM/beneficios CV (no\ndemostrado en prevención AVC)",
        "guid": "",
        "children": [
          {
            "id": "312",
            "parent": "311",
            "text": "• Alternativas: Clopidogrel 75 mg/día\n(intolerancia AAS) o Dipiridamol 200 mg\n2v/d (intolerancia AAS/Clop.)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "313",
        "parent": "0",
        "text": "• Revascularización",
        "guid": "",
        "children": []
      },
      {
        "id": "314",
        "parent": "0",
        "text": "→ Principalmente NO\nen asintomáticos",
        "guid": "",
        "children": []
      },
      {
        "id": "315",
        "parent": "0",
        "text": "→ Considerar si 60%-99% + ≥1 factor de\nriesgo elevado de AVC + riesgo proc. ≤3% +\nexpectativa vida >5 años",
        "guid": "",
        "children": []
      },
      {
        "id": "316",
        "parent": "0",
        "text": "→ CAS > CEA si riesgo qx alto\ny anatomía favorable",
        "guid": "",
        "children": []
      },
      {
        "id": "317",
        "parent": "0",
        "text": "→ NO revascularizar solo para\nreducir deterioro cognitivo en\n70%-99% asintomático",
        "guid": "",
        "children": [
          {
            "id": "318",
            "parent": "317",
            "text": "3. Seguimiento",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "319",
        "parent": "0",
        "text": "• Eco-Doppler anual si estenosis\n>50% → vigilar progresión y\nrespuesta terapéutica",
        "guid": "",
        "children": []
      },
      {
        "id": "320",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "321",
        "parent": "0",
        "text": "Dieta y Suplementos en\nEstenosis Carotídea",
        "guid": "vUfwMLfQ1K5IyGJCbVawIg",
        "children": [
          {
            "id": "322",
            "parent": "321",
            "text": "1. Recomendaciones\nGenerales (ESVS)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "323",
        "parent": "0",
        "text": "• Consejería conductual → dieta\nsana, cese tabáquico, actividad\nfísica (Clase I, B)",
        "guid": "",
        "children": [
          {
            "id": "324",
            "parent": "323",
            "text": "2. Vitamina C y\nFrutas/Bayas",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "325",
        "parent": "0",
        "text": "• Ensayo (Nutr Metab\nCardiovasc Dis 2009)",
        "guid": "",
        "children": []
      },
      {
        "id": "326",
        "parent": "0",
        "text": "• ↑ingesta vit. C + frutas/verduras\n→ menor progresión IMT (0,044\nmm vs 0,062 mm)",
        "guid": "",
        "children": [
          {
            "id": "327",
            "parent": "326",
            "text": "3. Vitaminas B\n(dosis altas)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "328",
        "parent": "0",
        "text": "• Ensayo (Stroke 2009)",
        "guid": "",
        "children": []
      },
      {
        "id": "329",
        "parent": "0",
        "text": "• No dif. global en\ngrosor íntima-media",
        "guid": "",
        "children": []
      },
      {
        "id": "330",
        "parent": "0",
        "text": "• Subgrupo con homocisteína basal ≥9,1\nµmol/L → ↓progresión carotídea",
        "guid": "",
        "children": [
          {
            "id": "331",
            "parent": "330",
            "text": "4. Niacina (2 g/día)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "332",
        "parent": "0",
        "text": "• Ensayo (J Am Coll\nCardiol 2009)",
        "guid": "",
        "children": []
      },
      {
        "id": "333",
        "parent": "0",
        "text": "• Px con estatinas + HDL <40\nmg/dL → ↓área pared carotídea\nen RM a 12 meses",
        "guid": "",
        "children": []
      },
      {
        "id": "334",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "335",
        "parent": "0",
        "text": "Terapia Médica en\nEstenosis de la A. Carótida",
        "guid": "jc5SsXbvpBUJD3H4F3akDQ",
        "children": [
          {
            "id": "336",
            "parent": "335",
            "text": "1. Consideraciones\nGenerales",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "337",
        "parent": "0",
        "text": "• Evaluar y tratar otros FR (HTA,\ndislipidemia, DM, tabaquismo, etc.)",
        "guid": "",
        "children": []
      },
      {
        "id": "338",
        "parent": "0",
        "text": "• Cambios de estilo de vida (dieta\nsaludable, ejercicio, cese tabaco)",
        "guid": "",
        "children": [
          {
            "id": "339",
            "parent": "338",
            "text": "2. Ensayo de “Terapia Médica\nIntensiva” en Asintomáticos\n(Arch Neurol 2010)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "340",
        "parent": "0",
        "text": "• Px con ≥60% estenosis → estatinas a dosis\nmáxima ± ezetimibe ± niacina/fibratos,\nIECA/ARA-II, control óptimo de PA y manejo\nde resistencia a la insulina",
        "guid": "",
        "children": []
      },
      {
        "id": "341",
        "parent": "0",
        "text": "• Comparado vs.\nterapia estándar:",
        "guid": "",
        "children": [
          {
            "id": "342",
            "parent": "341",
            "text": "• ↓Eventos CV (5,6% vs\n17,6%; p<0,001)",
            "guid": "",
            "children": []
          },
          {
            "id": "343",
            "parent": "341",
            "text": "• ↓Microémbolos (3,7%\nvs 12,6%; p<0,001)",
            "guid": "",
            "children": []
          },
          {
            "id": "344",
            "parent": "341",
            "text": "• ↓Progresión de placa (23 mm² vs 69\nmm² en 1er año; p<0,001)",
            "guid": "",
            "children": []
          },
          {
            "id": "345",
            "parent": "341",
            "text": "3. Anticoagulación\nUrgente",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "346",
        "parent": "0",
        "text": "• Eficacia incierta en estenosis\nsevera ipsilateral a AVC\nisquémico (Clase IIb, B-NR)",
        "guid": "",
        "children": [
          {
            "id": "347",
            "parent": "346",
            "text": "4. Factores Clave para Reducir\nRiesgo (Stroke 2013)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "348",
        "parent": "0",
        "text": "• Px asintomáticos con ≥1 año de\nseguimiento y terapia (estatinas +\nantihipertensivos + antiagregantes)",
        "guid": "",
        "children": []
      },
      {
        "id": "349",
        "parent": "0",
        "text": "• Ningún AVC ipsilateral en\nquienes usaban las 3 terapias",
        "guid": "",
        "children": []
      },
      {
        "id": "350",
        "parent": "0",
        "text": "• Antiagregantes + TA más baja → menor\nriesgo de AVC/TIA ipsilateral",
        "guid": "",
        "children": []
      },
      {
        "id": "351",
        "parent": "0",
        "text": "• Antiagregantes + antihipertensivos →\nmenor riesgo de AVC/ muerte CV",
        "guid": "",
        "children": []
      },
      {
        "id": "352",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "353",
        "parent": "0",
        "text": "Terapia Antitrombótica en\nEstenosis de la A. Carótida",
        "guid": "bABeTR7WbFXGjWJfRz6hXQ",
        "children": [
          {
            "id": "354",
            "parent": "353",
            "text": "1. Visión General",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "355",
        "parent": "0",
        "text": "• Organismos (ACCP, ASA/ACCF/AHA,\nESVS) recomiendan antiagregantes en\nestenosis sintomática y asintomática",
        "guid": "",
        "children": []
      },
      {
        "id": "356",
        "parent": "0",
        "text": "• Opciones principales:",
        "guid": "",
        "children": [
          {
            "id": "357",
            "parent": "356",
            "text": "• AAS 75-325 mg/día",
            "guid": "",
            "children": []
          },
          {
            "id": "358",
            "parent": "356",
            "text": "• Clopidogrel 75 mg/día",
            "guid": "",
            "children": []
          },
          {
            "id": "359",
            "parent": "356",
            "text": "• AAS/dipiridamol de liberación\nprolongada (25/200 mg 2v/d)",
            "guid": "",
            "children": []
          },
          {
            "id": "360",
            "parent": "356",
            "text": "2. Recomendaciones\nACCP (2012)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "361",
        "parent": "0",
        "text": "• Sintomáticos (incl.\npost-endarterectomía): terapia\nantiagregante a largo plazo (1A)",
        "guid": "",
        "children": []
      },
      {
        "id": "362",
        "parent": "0",
        "text": "→ Clopidogrel 75 mg/día o\nAAS/Dipiridamol o AAS 75-100 mg/día",
        "guid": "",
        "children": []
      },
      {
        "id": "363",
        "parent": "0",
        "text": "→ Preferencia: Clopidogrel o\nAAS/Dipiridamol sobre AAS sola (2B)",
        "guid": "",
        "children": []
      },
      {
        "id": "364",
        "parent": "0",
        "text": "• Asintomáticos: AAS 75-100\nmg/día sugerida (2B)",
        "guid": "",
        "children": [
          {
            "id": "365",
            "parent": "364",
            "text": "3. Recomendaciones\nASA/ACCF/AHA (2011)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "366",
        "parent": "0",
        "text": "• Aterosclerosis\nextra/vertebral (sintomática o\nno)",
        "guid": "",
        "children": []
      },
      {
        "id": "367",
        "parent": "0",
        "text": "→ AAS 75-325 mg/día para\nprevención IAM/eventos CV (I, A)",
        "guid": "",
        "children": []
      },
      {
        "id": "368",
        "parent": "0",
        "text": "• Con TIA/AVC",
        "guid": "",
        "children": []
      },
      {
        "id": "369",
        "parent": "0",
        "text": "→ Antiagregación (AAS, Clopidogrel\no AAS/Dipiridamol) (I, B)",
        "guid": "",
        "children": []
      },
      {
        "id": "370",
        "parent": "0",
        "text": "→ Evitar AAS + Clopidogrel largos\nen AVC/TIA reciente (III, B)",
        "guid": "",
        "children": []
      },
      {
        "id": "371",
        "parent": "0",
        "text": "• Prefieren antiagregantes vs\nanticoagulación en\naterosclerosis extracraneal",
        "guid": "",
        "children": [
          {
            "id": "372",
            "parent": "371",
            "text": "4. Recomendaciones\nESVS (2023)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "373",
        "parent": "0",
        "text": "4.1) Sintomáticos",
        "guid": "",
        "children": []
      },
      {
        "id": "374",
        "parent": "0",
        "text": "• AVC leve/TIA sin CEA → AAS+Clopidogrel x21\ndías → luego monoterapia Clopidogrel, o\nAAS+Dipiridamol largo plazo (I, A)",
        "guid": "",
        "children": []
      },
      {
        "id": "375",
        "parent": "0",
        "text": "• Si CEA planeada → mantener\nantiagregantes en perioperatorio (I, A)",
        "guid": "",
        "children": []
      },
      {
        "id": "376",
        "parent": "0",
        "text": "• CAS planeado → AAS+Clopidogrel al\nmenos 3 días antes → continuar ≥4 sem\nposstent → luego monoterapia",
        "guid": "",
        "children": []
      },
      {
        "id": "377",
        "parent": "0",
        "text": "4.2) Asintomáticos",
        "guid": "",
        "children": []
      },
      {
        "id": "378",
        "parent": "0",
        "text": "• >50% estenosis → considerar\nAAS 75-325 mg/día (IIa, C)",
        "guid": "",
        "children": []
      },
      {
        "id": "379",
        "parent": "0",
        "text": "• Alternativas: Clopidogrel 75\nmg/día o Dipiridamol 200 mg\n2v/día (intolerancias)",
        "guid": "",
        "children": [
          {
            "id": "380",
            "parent": "379",
            "text": "5. Expert Panel en\nMujeres (2013)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "381",
        "parent": "0",
        "text": "• Toda mujer con 50%-99%\nestenosis → manejo médico +\nantiplq. en perioperatorio",
        "guid": "",
        "children": []
      },
      {
        "id": "382",
        "parent": "0",
        "text": "• CEA → 1\nantiagregante (p.ej.\nAAS)",
        "guid": "",
        "children": []
      },
      {
        "id": "383",
        "parent": "0",
        "text": "• CAS → dual\n(AAS+Clopidogrel o\nTiclopidina) ≥3 días antes y ≥1\nmes después",
        "guid": "",
        "children": []
      },
      {
        "id": "384",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "385",
        "parent": "0",
        "text": "Antiplaquetarios en CEA\n(Carotid Endarterectomy)",
        "guid": "CfmdjCmUQbYd3eofQ4jQqQ",
        "children": [
          {
            "id": "386",
            "parent": "385",
            "text": "1. Evidencia General\n(Cochrane 2003)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "387",
        "parent": "0",
        "text": "• 6 ensayos, 907 px → uso de\nantiagregantes ≥30 días pos-CEA",
        "guid": "",
        "children": []
      },
      {
        "id": "388",
        "parent": "0",
        "text": "• ↓riesgo de AVC (no hubo conclusiones\nfirmes en otros desenlaces)",
        "guid": "",
        "children": [
          {
            "id": "389",
            "parent": "388",
            "text": "2. Dosis de Aspirina\nPerioperatoria (Ensayo Lancet\n1999)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "390",
        "parent": "0",
        "text": "• 2.849 px con CEA\nrandomizados a ASA 81 mg,\n325 mg, 650 mg o 1.300 mg",
        "guid": "",
        "children": []
      },
      {
        "id": "391",
        "parent": "0",
        "text": "• Menor riesgo combinado de AVC, IAM y\nmuerte a 3 meses con dosis bajas (81-325\nmg) vs altas (650-1.300 mg)",
        "guid": "",
        "children": []
      },
      {
        "id": "392",
        "parent": "0",
        "text": "→ 6,2% vs 8,\n4% (p=0,03)",
        "guid": "",
        "children": []
      },
      {
        "id": "393",
        "parent": "0",
        "text": "En Pacientes Que No Se Someterán a\nEndarterectomía Carotídea",
        "guid": "DqQGEars5tIKZuCIra7vJA",
        "children": [
          {
            "id": "394",
            "parent": "393",
            "text": "1. Aspirina 325 mg/día\nen Asintomáticos",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "395",
        "parent": "0",
        "text": "• Estudio (Ann Intern Med 1995) con 372\npx ≥50% estenosis + soplo",
        "guid": "",
        "children": []
      },
      {
        "id": "396",
        "parent": "0",
        "text": "• Seguimiento 2,3 años",
        "guid": "",
        "children": []
      },
      {
        "id": "397",
        "parent": "0",
        "text": "• Aspirina vs Placebo → sin diferencia en\neventos isquémicos o mortalidad",
        "guid": "",
        "children": [
          {
            "id": "398",
            "parent": "397",
            "text": "2. Doble Antiagregación\n(Clopidogrel + AAS)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "399",
        "parent": "0",
        "text": "• Estudio (Circulation 2005) con 107 px con\nestenosis sintomática reciente y microémbolos\n(no programados para CEA)",
        "guid": "",
        "children": []
      },
      {
        "id": "400",
        "parent": "0",
        "text": "• A 7 días → TIA/AVC ipsilateral 7,8% (dupla) vs\n19,6% (monoterapia) (no significativo\nestadísticamente; p no informado)",
        "guid": "",
        "children": [
          {
            "id": "401",
            "parent": "400",
            "text": "3. Cilostazol vs Aspirina",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "402",
        "parent": "0",
        "text": "• Estudio DAPC (Circulation\n2010) en 329 px DM2 + PAD\nasintomática (2 años)",
        "guid": "",
        "children": []
      },
      {
        "id": "403",
        "parent": "0",
        "text": "• Cilostazol → ↓progresión grosor\níntima-media carotídea vs AAS",
        "guid": "",
        "children": []
      },
      {
        "id": "404",
        "parent": "0",
        "text": "• Sin datos clínicos (solo\ncambio en IMT)",
        "guid": "",
        "children": []
      },
      {
        "id": "405",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "406",
        "parent": "0",
        "text": "Terapia Antihipertensiva en\nEstenosis de la A. Carótida",
        "guid": "y6-w8xNsf1U0zfcULaiz0A",
        "children": [
          {
            "id": "407",
            "parent": "406",
            "text": "1. Recomendaciones\nASA/ACCF/AHA (2011)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "408",
        "parent": "0",
        "text": "• Asintomáticos: mantener PA\n<140/90 mm Hg (I, A).",
        "guid": "",
        "children": []
      },
      {
        "id": "409",
        "parent": "0",
        "text": "• Sintomáticos: tratar HTA fuera del\nperíodo hiperagudo; no se conoce\nmeta específica (IIa, C).",
        "guid": "",
        "children": [
          {
            "id": "410",
            "parent": "409",
            "text": "2. Recomendaciones\nESVS (2023)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "411",
        "parent": "0",
        "text": "• Sintomáticos",
        "guid": "",
        "children": [
          {
            "id": "412",
            "parent": "411",
            "text": "• Tratar HTA en\nTIA/AVC menor (I, A).",
            "guid": "",
            "children": []
          },
          {
            "id": "413",
            "parent": "411",
            "text": "• Si CEA/CAS temprano, evitar descensos\nbruscos de PA aunque HTA >180/90 mm\nHg debe tratarse (IIa, C).",
            "guid": "",
            "children": []
          },
          {
            "id": "414",
            "parent": "411",
            "text": "• Post-trombólisis IV, controlar\nPA para ↓riesgo hemorragia\nparenquimatosa (I, C).",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "415",
        "parent": "0",
        "text": "• Asintomáticos",
        "guid": "",
        "children": [
          {
            "id": "416",
            "parent": "415",
            "text": "• Iniciar\nantihipertensivos si\nHTA (I, A).",
            "guid": "",
            "children": []
          },
          {
            "id": "417",
            "parent": "415",
            "text": "3. Mujeres (Expert Panel)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "418",
        "parent": "0",
        "text": "• Control de PA <140/80 mm Hg\nideal, dentro de manejo médico\nintegral (Grado 1, Nivel A).",
        "guid": "",
        "children": [
          {
            "id": "419",
            "parent": "418",
            "text": "4. Evidencia Cochrane\n2023 (limitada)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "420",
        "parent": "0",
        "text": "• Metoprolol 25 mg/día vs placebo → sin\nreducción significativa de AVC ipsilateral o\nmortalidad específica.",
        "guid": "",
        "children": []
      },
      {
        "id": "421",
        "parent": "0",
        "text": "• Un ensayo con chlortalidona 12,5\nmg/día redujo progresión de estenosis\n(14% vs 31%, p<0,05).",
        "guid": "",
        "children": []
      },
      {
        "id": "422",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "423",
        "parent": "0",
        "text": "Estatinas en\nEstenosis\nCarotídea",
        "guid": "n8y6a2QxFP7Yw-_Sai29VQ",
        "children": [
          {
            "id": "424",
            "parent": "423",
            "text": "1. Recomendaciones\nASA/ACCF/AHA (2011)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "425",
        "parent": "0",
        "text": "• Todo px con aterosclerosis\ncarotídea/vertebral → estatinas\npara LDL <100 mg/dL (I, B).",
        "guid": "",
        "children": []
      },
      {
        "id": "426",
        "parent": "0",
        "text": "• En px con AVC isquémico →\nrazonable LDL ~70 mg/dL (IIa, B).",
        "guid": "",
        "children": []
      },
      {
        "id": "427",
        "parent": "0",
        "text": "• Si no se logra meta con\nestatina: intensificar con\nfármacos adicionales (IIa, B).",
        "guid": "",
        "children": []
      },
      {
        "id": "428",
        "parent": "0",
        "text": "• Intolerancia a estatinas: resinas de\nácidos biliares / niacina (IIa, B).",
        "guid": "",
        "children": []
      },
      {
        "id": "429",
        "parent": "0",
        "text": "• DM + estenosis: estatinas para\nLDL ~70 mg/dL (IIa, B).",
        "guid": "",
        "children": [
          {
            "id": "430",
            "parent": "429",
            "text": "2. Recomendaciones\nESVS (2023)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "431",
        "parent": "0",
        "text": "• Sintomáticos",
        "guid": "",
        "children": [
          {
            "id": "432",
            "parent": "431",
            "text": "• Estatinas a largo\nplazo (I, B).",
            "guid": "",
            "children": []
          },
          {
            "id": "433",
            "parent": "431",
            "text": "• Añadir ezetimibe si no se\nalcanza objetivo (I, B).",
            "guid": "",
            "children": []
          },
          {
            "id": "434",
            "parent": "431",
            "text": "• PCSK9 si intolerancia o no se\nlogran metas con estatinas ±\nezetimibe (IIa, B).",
            "guid": "",
            "children": []
          },
          {
            "id": "435",
            "parent": "431",
            "text": "• Iniciar estatinas antes\nde CEA/CAS (I, A).",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "436",
        "parent": "0",
        "text": "• Asintomáticos",
        "guid": "",
        "children": [
          {
            "id": "437",
            "parent": "436",
            "text": "• Comenzar estatinas ± ezetimibe\npara prevención CV (I, B).",
            "guid": "",
            "children": []
          },
          {
            "id": "438",
            "parent": "436",
            "text": "• PCSK9 si intolerancia a\nestatinas (IIa, C).",
            "guid": "",
            "children": []
          },
          {
            "id": "439",
            "parent": "436",
            "text": "• No suspender estatinas previo a\ncirugía no cardiaca (III, C).",
            "guid": "",
            "children": []
          },
          {
            "id": "440",
            "parent": "436",
            "text": "3. Mujeres (Expert Panel)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "441",
        "parent": "0",
        "text": "• ≥50% estenosis → manejo\nmédico siempre, incluyendo\nestatinas (LDL <100 mg/dL).",
        "guid": "",
        "children": [
          {
            "id": "442",
            "parent": "441",
            "text": "4. Cochrane 2023\n(Asintomáticos)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "443",
        "parent": "0",
        "text": "• No reducción estadísticamente significativa en AVC\nipsilateral mayor/inválido ni mortalidad específica de AVC\n(IC amplios → no descartan beneficio).",
        "guid": "",
        "children": []
      },
      {
        "id": "444",
        "parent": "0",
        "text": "• Duración de 2-6 años, fármacos:\natorvastatina, lovastatina,\npravastatina, rosuvastatina.",
        "guid": "",
        "children": []
      },
      {
        "id": "445",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "446",
        "parent": "0",
        "text": "Terapia Hipoglucemiante en\nEstenosis Carotídea",
        "guid": "obJetVJ7spY66oo92nmQJg",
        "children": [
          {
            "id": "447",
            "parent": "446",
            "text": "1. Recomendaciones\nPrincipales",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "448",
        "parent": "0",
        "text": "• ASA/ACCF/AHA: px con DM + aterosclerosis\ncarotídea/vertebral → dieta + ejercicio +\nfármacos hipoglucemiantes (IIa, A).",
        "guid": "",
        "children": [
          {
            "id": "449",
            "parent": "448",
            "text": "• No se ha establecido beneficio en\nprevención de AVC con control\nintensivo (HbA1c <7%).",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "450",
        "parent": "0",
        "text": "• ESVS: control óptimo de la glucemia en\npx asintomáticos con DM (I, B).",
        "guid": "",
        "children": [
          {
            "id": "451",
            "parent": "450",
            "text": "2. Evidencia (ORIGIN-GRACE,\nDiabetes Care 2013)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "452",
        "parent": "0",
        "text": "• Ensayo en 1.184 px con\nriesgos CV + intolerancia a la\nglucosa o DM2 temprano.",
        "guid": "",
        "children": []
      },
      {
        "id": "453",
        "parent": "0",
        "text": "• Comparó insulina glargina (glucemia en\nayunas ≤95 mg/dL) vs cuidado estándar\n(seguimiento ~4,9 años).",
        "guid": "",
        "children": []
      },
      {
        "id": "454",
        "parent": "0",
        "text": "• Insulina glargina →\n↓progresión del espesor\níntima-media carotídeo (p≤0,\n05).",
        "guid": "",
        "children": []
      },
      {
        "id": "455",
        "parent": "0",
        "text": "• Suplementos de ácidos grasos\nn-3 → sin diferencias.",
        "guid": "",
        "children": [
          {
            "id": "456",
            "parent": "455",
            "text": "3. Otros Datos",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "457",
        "parent": "0",
        "text": "• No hay ensayos específicos en\nestenosis carotídea asintomática\n(Cochrane 2023).",
        "guid": "",
        "children": []
      },
      {
        "id": "458",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "459",
        "parent": "0",
        "text": "Procedimientos Quirúrgicos\ny Revascularización",
        "guid": "0Io-RfvQbHXUuTwaRxrGGw",
        "children": [
          {
            "id": "460",
            "parent": "459",
            "text": "1. General",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "461",
        "parent": "0",
        "text": "• <50% estenosis → NO revascularizar\nen la mayoría de los casos",
        "guid": "",
        "children": [
          {
            "id": "462",
            "parent": "461",
            "text": "2. Pacientes Sintomáticos",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "463",
        "parent": "0",
        "text": "• Revascularizar idealmente en\nlas 2 sem post-AIT/AVC (si no hay\ncontraindicaciones)",
        "guid": "",
        "children": []
      },
      {
        "id": "464",
        "parent": "0",
        "text": "• Opción si 50%-99% estenosis +\nsíntomas en últimos 6 meses + riesgo\nproced. (muerte/AVC) <6%",
        "guid": "",
        "children": []
      },
      {
        "id": "465",
        "parent": "0",
        "text": "• CEA en 70%-99%\n(mandatorio)",
        "guid": "",
        "children": []
      },
      {
        "id": "466",
        "parent": "0",
        "text": "• CEA a considerar\nen 50%-69%",
        "guid": "",
        "children": []
      },
      {
        "id": "467",
        "parent": "0",
        "text": "• CAS alternativa\nsi <70 años",
        "guid": "",
        "children": [
          {
            "id": "468",
            "parent": "467",
            "text": "3. Pacientes\nAsintomáticos",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "469",
        "parent": "0",
        "text": "• Mayoría no requiere\nrevascularización",
        "guid": "",
        "children": []
      },
      {
        "id": "470",
        "parent": "0",
        "text": "• Considerar si 60%-99% + ≥1 factor de alto\nriesgo de AVC + riesgo proced. ≤3% +\nexpectativa de vida >5 años",
        "guid": "",
        "children": []
      },
      {
        "id": "471",
        "parent": "0",
        "text": "• CAS preferible sobre CEA si alto\nriesgo qx + anatomía favorable",
        "guid": "",
        "children": []
      },
      {
        "id": "472",
        "parent": "0",
        "text": "• NO revascularizar solo para reducir deterioro\ncognitivo en 70%-99% asintomático (ausencia de\nasociación causal demostrada)",
        "guid": "",
        "children": [
          {
            "id": "473",
            "parent": "472",
            "text": "4. Manejo Perioperatorio",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "474",
        "parent": "0",
        "text": "•\nAntiagregación\ncontinua:",
        "guid": "",
        "children": [
          {
            "id": "475",
            "parent": "474",
            "text": "• CEA → AAS\n75-325 mg/día",
            "guid": "",
            "children": []
          },
          {
            "id": "476",
            "parent": "474",
            "text": "• CAS → dual (AAS\n+ Clopidogrel)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "477",
        "parent": "0",
        "text": "• Considerar sistemas de\nprotección cerebral en CAS",
        "guid": "",
        "children": []
      },
      {
        "id": "478",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "479",
        "parent": "0",
        "text": "Otras Medidas en el Manejo de\nla Estenosis Carotídea",
        "guid": "BGg_XPJJh9-6_k24C8wkQg",
        "children": [
          {
            "id": "480",
            "parent": "479",
            "text": "1. Enfoque\nMultidisciplinario",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "481",
        "parent": "0",
        "text": "• ESVS sugiere equipo multidisciplinario\npara decidir CEA, CAS y terapia médica\nóptima (Clase I, C).",
        "guid": "",
        "children": [
          {
            "id": "482",
            "parent": "481",
            "text": "2. Cese de Tabaquismo",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "483",
        "parent": "0",
        "text": "• Indicar a los fumadores abandonar el\nhábito y ofrecer intervenciones de cesación\n(ASA/ACCF/AHA Clase I, B).",
        "guid": "",
        "children": []
      },
      {
        "id": "484",
        "parent": "0",
        "text": "• En mujeres con estenosis carotídea, abordar\nHTA, hipercolesterolemia y tabaquismo reduce el\nriesgo CV global (Grado 1, A).",
        "guid": "",
        "children": [
          {
            "id": "485",
            "parent": "484",
            "text": "3. Modificaciones en\nel Estilo de Vida",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "486",
        "parent": "0",
        "text": "• ESVS (Clase I, B) → Consejería dietética,\nactividad física y cese tabáquico para\nsintomáticos y asintomáticos.",
        "guid": "",
        "children": []
      },
      {
        "id": "487",
        "parent": "0",
        "text": "• Ejercicio: beneficio incierto más\nallá de los efectos en pérdida de\npeso, lípidos y glucemia.",
        "guid": "",
        "children": [
          {
            "id": "488",
            "parent": "487",
            "text": "4. “Remote Ischemic\nConditioning” (RIC)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "489",
        "parent": "0",
        "text": "• Meta-análisis Cochrane 2018 (7 ensayos,\nlimitaciones metodológicas).",
        "guid": "",
        "children": []
      },
      {
        "id": "490",
        "parent": "0",
        "text": "• RIC asociado a ↓riesgo de AVC\nisquémico (RR 0,31, IC95%: 0,\n12-0,76; NNT ~13-47).",
        "guid": "",
        "children": []
      },
      {
        "id": "491",
        "parent": "0",
        "text": "• Aumento de eventos adversos\nleves (petequias cutáneas); sin\neventos severos reportados.",
        "guid": "",
        "children": []
      },
      {
        "id": "492",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "493",
        "parent": "0",
        "text": "Seguimiento en\nEstenosis Carotídea",
        "guid": "ecbTwrB6PSvXHClyoqQehA",
        "children": [
          {
            "id": "494",
            "parent": "493",
            "text": "1. Eco-Doppler Carotídeo",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "495",
        "parent": "0",
        "text": "• Repetir anualmente si >50%\nestenosis (ASA/ACCF/AHA IIa, C).",
        "guid": "",
        "children": []
      },
      {
        "id": "496",
        "parent": "0",
        "text": "• Ajustar frecuencia o suspender cuando la\nenfermedad se estabiliza o cambie la\nindicación de intervención.",
        "guid": "",
        "children": []
      },
      {
        "id": "497",
        "parent": "0",
        "text": "• Indicado control ecográfico si\nestenosis >20% en asintomáticos.",
        "guid": "",
        "children": [
          {
            "id": "498",
            "parent": "497",
            "text": "2. Progresión de\nla Estenosis",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "499",
        "parent": "0",
        "text": "• En estudio con 1.004 px\nasintomáticos (Arch Intern Med 2003):",
        "guid": "",
        "children": [
          {
            "id": "500",
            "parent": "499",
            "text": "• La progresión seriada de la estenosis\npredijo mayor riesgo de TIA/AVC\nipsilateral (RR 1,68 y 1,78).",
            "guid": "",
            "children": []
          },
          {
            "id": "501",
            "parent": "499",
            "text": "• El grado basal de estenosis se\nasoció a TIA/AVC combinado,\npero no a AVC solo.",
            "guid": "",
            "children": []
          },
          {
            "id": "502",
            "parent": "499",
            "text": "3. Fibrormuscular\nDisplasia (FMD)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "503",
        "parent": "0",
        "text": "• Control anual no invasivo\n(Eco-Doppler) para detectar cambios,\nal menos inicialmente (IIa, C).",
        "guid": "",
        "children": []
      },
      {
        "id": "504",
        "parent": "0",
        "text": "• Si estable, prolongar\nintervalos o reducir frecuencia.",
        "guid": "",
        "children": [
          {
            "id": "505",
            "parent": "504",
            "text": "4. Mujeres con\nEstenosis Carotídea",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "506",
        "parent": "0",
        "text": "• Mantener terapia médica óptima de por\nvida (antiagregantes, estatinas,\nantihipertensivos) (Grado 1, B).",
        "guid": "",
        "children": []
      },
      {
        "id": "507",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "508",
        "parent": "0",
        "text": "Pronóstico en Estenosis\nCarotídea Sintomática",
        "guid": "nqUABKYntdYhC7jecTXqlw",
        "children": [
          {
            "id": "509",
            "parent": "508",
            "text": "1. Riesgo de\nRecurrencia\nTemprana",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "510",
        "parent": "0",
        "text": "• Tras AIT/AVC leve y estenosis ≥70% →\n↑riesgo de recurrencia neurológica temprana\n(27,6% en 14 días; Stroke 2009).",
        "guid": "",
        "children": []
      },
      {
        "id": "511",
        "parent": "0",
        "text": "• AVC isquémico con estenosis ipsilateral\n≥50% → 5,6% recurrencia a 72 h vs 0,4% sin\nestenosis (Neurology 2011).",
        "guid": "",
        "children": [
          {
            "id": "512",
            "parent": "511",
            "text": "2. Restenosis\npost-Endarterectomía",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "513",
        "parent": "0",
        "text": "• 17% desarrolló ≥50%\nrestenosis a 1 año (JAMA 2008).",
        "guid": "",
        "children": []
      },
      {
        "id": "514",
        "parent": "0",
        "text": "• Menor riesgo si infiltración\nde macrófagos o gran núcleo\nlipídico en placa.",
        "guid": "",
        "children": [
          {
            "id": "515",
            "parent": "514",
            "text": "3. Monocular vs\nHemisférico (AIT)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "516",
        "parent": "0",
        "text": "• Ceguera monocular transitoria\n(amaurosis fugaz) → mejor pronóstico\nque AIT hemisférico (NEJM 2001).",
        "guid": "",
        "children": []
      },
      {
        "id": "517",
        "parent": "0",
        "text": "• Factores de riesgo en monocular: >75 años, varón,\nAIT/AVC hemisférico previo, claudicación, 80%-94%\nestenosis, colaterales ausentes.",
        "guid": "",
        "children": []
      },
      {
        "id": "518",
        "parent": "0",
        "text": "• Riesgo a 3 años\ncon tto médico:",
        "guid": "",
        "children": [
          {
            "id": "519",
            "parent": "518",
            "text": "• 1,8% con 0-1 factor",
            "guid": "",
            "children": []
          },
          {
            "id": "520",
            "parent": "518",
            "text": "• 12,3% con 2 factores",
            "guid": "",
            "children": []
          },
          {
            "id": "521",
            "parent": "518",
            "text": "• 24,2% con ≥3 factores",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "522",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "523",
        "parent": "0",
        "text": "Pronóstico en Estenosis\nCarotídea Asintomática",
        "guid": "7i1v_etUEv3vmNsQP3_vmQ",
        "children": [
          {
            "id": "524",
            "parent": "523",
            "text": "1. Riesgo de AVC\nIpsilateral y Mortalidad",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "525",
        "parent": "0",
        "text": "• Cohorte JAMA 2022 (N=3.737,\nestenosis 70%-99%):",
        "guid": "",
        "children": [
          {
            "id": "526",
            "parent": "525",
            "text": "• Riesgo de AVC ipsilateral a 5 años\n≈4,7% (tasa anual ≈0,9%).",
            "guid": "",
            "children": []
          },
          {
            "id": "527",
            "parent": "525",
            "text": "• Mortalidad general a 5 años\n≈45% (tasa anual ≈13,6%).",
            "guid": "",
            "children": []
          },
          {
            "id": "528",
            "parent": "525",
            "text": "• Uso de estatinas se asoció con\nmenor riesgo de AVC (HR 0,38).",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "529",
        "parent": "0",
        "text": "• Meta-análisis Ann Intern Med 2013: tasa\nde AVC ipsilateral ~1,68%/año.",
        "guid": "",
        "children": []
      },
      {
        "id": "530",
        "parent": "0",
        "text": "• Revisión sistemática Stroke 2016\n(oclusión carotídea asintomática):",
        "guid": "",
        "children": [
          {
            "id": "531",
            "parent": "530",
            "text": "• Tasa anual de AVC\nipsilateral ≈1,3%.",
            "guid": "",
            "children": []
          },
          {
            "id": "532",
            "parent": "530",
            "text": "• Mortalidad por todas las\ncausas ≈7,7%/año.",
            "guid": "",
            "children": []
          },
          {
            "id": "533",
            "parent": "530",
            "text": "2. Impacto del\nGrado de Estenosis",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "534",
        "parent": "0",
        "text": "• Lancet Neurol 2021 (56 estudios,\n+1 cohorte prospectiva):",
        "guid": "",
        "children": [
          {
            "id": "535",
            "parent": "534",
            "text": "• Riesgo anual de AVC ipsilateral\nha disminuido <1% tras 2010 con\nmejor terapia médica.",
            "guid": "",
            "children": []
          },
          {
            "id": "536",
            "parent": "534",
            "text": "• Estenosis ≥70%-99% → riesgo\nmayor que 50%-69%.",
            "guid": "",
            "children": []
          },
          {
            "id": "537",
            "parent": "534",
            "text": "• Cohorte Oxford (5,9\naños seguimiento):",
            "guid": "",
            "children": []
          },
          {
            "id": "538",
            "parent": "534",
            "text": "• 18,3% AVC ipsilateral a 5 años en\n80%-99% vs 1% en 50%-79%.",
            "guid": "",
            "children": []
          },
          {
            "id": "539",
            "parent": "534",
            "text": "3. Otras\nComplicaciones y\nHallazgos",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "540",
        "parent": "0",
        "text": "• Progresión de estenosis en Duplex\nseriado se asocia a mayor riesgo de\neventos CV (Stroke 2007).",
        "guid": "",
        "children": []
      },
      {
        "id": "541",
        "parent": "0",
        "text": "• Riesgo de IAM y muerte vascular puede\nsuperar al de AVC ipsilateral a largo\nplazo (Arch Neurol 2002).",
        "guid": "",
        "children": []
      },
      {
        "id": "542",
        "parent": "0",
        "text": "• Características de placa (microémbolos en\nTCD, placas hipolúcidas) → mayor riesgo\nde eventos isquémicos.",
        "guid": "",
        "children": []
      },
      {
        "id": "543",
        "parent": "0",
        "text": "• Estenosis carotídea izquierda\nsevera → posible deterioro cognitivo\n(Ann Intern Med 2004).",
        "guid": "",
        "children": [
          {
            "id": "544",
            "parent": "543",
            "text": "4. Factores de\nProgresión (ICA/CCA\nratio)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "545",
        "parent": "0",
        "text": "• ICA/CCA >2,5 → ↑probabilidad\nde progresar a estenosis ≥70% (J\nVasc Surg 2014).",
        "guid": "",
        "children": []
      },
      {
        "id": "546",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      },
      {
        "id": "547",
        "parent": "0",
        "text": "Prevención y Cribado de la\nEstenosis Carotídea",
        "guid": "2MAuXo-SUR7tD5DEVpR10Q",
        "children": [
          {
            "id": "548",
            "parent": "547",
            "text": "1. Prevención",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "549",
        "parent": "0",
        "text": "• No aplica (no hay intervenciones\npreventivas específicas distintas a las de\nreducir factores de riesgo vascular).",
        "guid": "",
        "children": [
          {
            "id": "550",
            "parent": "549",
            "text": "2. Cribado en\nPoblación\nAsintomática",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "551",
        "parent": "0",
        "text": "• No se recomienda cribado rutinario en\nla población general (USPSTF Grade\nD, ESVS Clase III, C).",
        "guid": "",
        "children": []
      },
      {
        "id": "552",
        "parent": "0",
        "text": "• Puede considerarse en grupos selectos de\nalto riesgo si existe disposición a una\nintervención carotídea en caso de estenosis\nsignificativa (SVS Grado 2, B).",
        "guid": "",
        "children": [
          {
            "id": "553",
            "parent": "552",
            "text": "3. Situaciones\nEspecíficas (ESVS)",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "554",
        "parent": "0",
        "text": "3.1) ≥2 Factores de\nRiesgo Vascular",
        "guid": "",
        "children": []
      },
      {
        "id": "555",
        "parent": "0",
        "text": "• Cribado (Eco-Doppler) opcional para mejorar\nel control de factores de riesgo, no para\nintervención invasiva (IIb, B).",
        "guid": "",
        "children": []
      },
      {
        "id": "556",
        "parent": "0",
        "text": "3.2) Cirugía Cardíaca (Bypass Coronario\n/ Cirugía Cardiaca Abierta)",
        "guid": "",
        "children": []
      },
      {
        "id": "557",
        "parent": "0",
        "text": "• No realizar cribado rutinario de\ncarótida (Clase III, C).",
        "guid": "",
        "children": []
      },
      {
        "id": "558",
        "parent": "0",
        "text": "• Considerar Eco-Doppler si edad >70 años,\nTIA/AVC previos, soplo carotídeo o estenosis de\ntronco coronario izquierdo (IIa, C).",
        "guid": "",
        "children": []
      },
      {
        "id": "559",
        "parent": "0",
        "text": "3.3) Cirugía No Cardíaca",
        "guid": "",
        "children": []
      },
      {
        "id": "560",
        "parent": "0",
        "text": "• No se recomienda imagen rutinaria de\ncarótidas en asintomáticos (III, B).",
        "guid": "",
        "children": []
      },
      {
        "id": "561",
        "parent": "0",
        "text": "• Realizar imagen si TIA/AVC <6 meses\nantes de cirugía electiva (I, B).",
        "guid": "",
        "children": [
          {
            "id": "562",
            "parent": "561",
            "text": "4. Métodos de Cribado",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "563",
        "parent": "0",
        "text": "• Eco-Doppler en laboratorio\nacreditado preferido sobre\nCTA/MRA (SVS Grado 1, B).",
        "guid": "",
        "children": [
          {
            "id": "564",
            "parent": "563",
            "text": "5. Justificación",
            "guid": "",
            "children": []
          }
        ]
      },
      {
        "id": "565",
        "parent": "0",
        "text": "• Alta tasa de falsos positivos\nen población general.",
        "guid": "",
        "children": []
      },
      {
        "id": "566",
        "parent": "0",
        "text": "• Beneficio clínico limitado en asintomáticos\ncon intervención (CEA/CAS).",
        "guid": "",
        "children": []
      },
      {
        "id": "567",
        "parent": "0",
        "text": "• Posibles daños asociados a pruebas\nconfirmatorias e intervenciones.",
        "guid": "",
        "children": []
      },
      {
        "id": "568",
        "parent": "0",
        "text": "Fin.",
        "guid": "",
        "children": []
      }
    ]
  },
  "node_count": 569,
  "relations": [],
  "cross_references": [
    {
      "from_node": "513",
      "reference": "JAMA"
    },
    {
      "from_node": "516",
      "reference": "NEJM"
    }
  ],
  "specialty": "General",
  "folder": "- Entidades clínicas/General",
  "filename": "Estenosis carotídea-2025",
  "id": "map_693",
  "resolved_references": []
}